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I. Overview
Enzymes that generate carbanionic intermediates often catalyze paracatalytic reactions with
O2 and other electrophiles not considered “normal” reactants. For example, pyridoxal 5′-
phosphate (PLP)—containing pig kidney dopa decarboxylase oxidizes dopamine with
molecular O2 to 3,4-dihydroxyphenylacetaldehyde at about 1% of the rate at which it
catalyzes nonoxidative dopa decarboxylation. The mutant Y332F enzyme, however,
catalyzes stoichiometric conversion of dopa to 3,4-dihydroxyphenylacetaldehyde,
suggesting that even minor structural changes may alter or initiate paracatalytic reactions
catalyzed by certain enzymes. Carbanions generated by several thiamine diphosphate
(ThDP)—dependent enzymes react with different electrophiles, transforming some
xenobiotics and endogenous compounds into potentially biologically hazardous products.
The detrimental effects of paracatalytic reactions may be greatly increased by cellular
compartmentation of enzymes and intermediates. For example, in two of the the three
multienzyme complexes involved in oxidative α-keto acid decarboxylation, paracatalytic
reactions of the third component inactivate the first carbanion-generating component.
In this review we provide an outline of carbanion-generating enzymes known to catalyze
paracatalytic reactions. We also discuss the potential of some of these reactions to contribute
to irreversible damage in cancer and neurodegeneration through disease-induced alterations
in the metabolic state and/or protein structure.
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II. Paracatalytic Reactions: Definition
In a series of seminal articles published more than 25 years ago, Philipp Christen and co-
workers showed that the carbanionic intermediates of several enzymes [e.g., class I and class
II fructose 1,6-bisphosphate aldolase, 6-phosphogluconate dehydrogenase, cytosolic
aspartate aminotransferase, and pyruvate decarboxylase (PDC)] were accessible to various
oxidants (electrophiles). Depending on the enzyme, these oxidants included, for example,
2,6-dichloroindophenol (DCIP), hexacyanoferrate(III), porphyrindin, tetranitromethane, and
H2O2 (1–8). Christen coined the word paracatalytic to describe enzyme-catalyzed
interactions between substrate and a reagent (especially an oxidant) not generally considered
to be a physiological reactant (4, 5, 7). Reactions of enzyme-generated carbanions with O2
were not included in Christen's original definition of paracatalytic reactions. However,
several enzymes have been shown to catalyze oxidative side reactions with O2 as the
oxidant.1 Therefore, in the present chapter we include enzyme-catalyzed oxidation side
reactions with O2 as a type of paracatalytic reaction. In many cases, the side products,
whether generated from an artificial electron acceptor or from O2, are reactive and can lead
to inactivation of the enzyme catalyzing the reaction or result in other types of oxidative
damage. These reactive species might also be released from the active site of one enzyme to
affect neighboring enzymes and macromolecules within the cellular milieu. As discussed
below, these para-catalytic side reactions may contribute to disease processes.
III. Discovery of Enzyme-Catalyzed Oxygenase Side Reactions: Rubisco
Originally it was not suspected that enzymes catalyzing reactions with carbanionic
intermediates might also catalyze reactions with O2. Therefore, it came as a surprise to
enzymologists when it was shown that ribulose 1,5-bisphosphate carboxylase is capable of
catalyzing an oxygenase reaction [see the article by Bowes and Ogren (9) for the original
discovery]. Since ribulose 1,5-bisphosphate carboxylase was the first enzyme shown to
catalyze an unexpected oxygenase side reaction, we include a discussion of this enzyme here
for historical reasons and to use this enzyme as a prototype in our discussion of enzyme-
catalyzed oxidase/oxygenase side reactions.
Ribulose 1,5-bisphosphate carboxylase, which is probably the most abundant enzyme on
earth, catalyzes the first and controlling step of carbon fixation in photosynthesis (capture of
atmospheric CO2 to form 3-phosphoglycerate). However, ribulose 1,5-bisphosphate
carboxylase also catalyzes carbon photorespiration (consumption of O2 with concomitant
production of 2-phosphoglycolate) (9–12). Because of this finding, the enzyme is now
generally referred to as ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco).
Photosynthesis results in a net gain of carbon biomass, whereas photorespiration does not.
Photorespiration is energetically inefficient because it does not capture released energy as
ATP or as a reduced nicotinamide adenine dinucleotide (phosphate). Thus, the oxygenase
activity of Rubisco impedes the carbon biomass productivity of plants (9).
1In this chapter we use the Enzyme Commission guidelines in defining oxygenases and oxidases. Oxygenases catalyze reactions in
which at least one O atom derived from molecular oxygen (O2) is incorporated into the main substrate. A monooxygenase catalyzes
the incorporation of one O atom into the main substrate (AH), generating AOH; the other O atom is reduced to water, with
concomitant oxidation of the co-substrate (BH2) to B. The reaction may be written formally as AH + BH2 + O2 → AOH + B + H2O.
Dioxygenases catalyze the incorporation of two O atoms into a substrate. In some cases a single oxidized product retains both O atoms
derived from O2. In other cases, however, oxidation may generate two identical products, each containing an O atom derived from
O2. In yet other cases, oxidation may yield two dissimilar products from a single substrate, each containing an O atom derived from
O2. Oxidases catalyze oxidation reactions in which electrons are removed from the substrate and are used to reduce an electron
acceptor, usually, but not always, O2. A one-electron reduction of O2 will generate superoxide anion radical (O2•−). More common is
a two-electron reduction of O2 to hydrogen peroxide (H2O2). In other cases, a four-electron reduction of O2 yields water. In none of
these three cases is O derived from O2 incorporated into the oxidized product.
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During CO2 fixation catalyzed by Rubisco, a carbanionic intermediate (enediolate) derived
from ribulose 1,5-bisphosphate reacts with CO2 to form a β-keto acid:
(1)
which then undergoes hydrolysis at the active site to yield two equivalents of D-3-
phosphoglycerate:
(2)
The net carbon gain is 1 (i.e., 5C + 1C → 3C + 3C). In the oxygenase reaction catalyzed by
Rubisco, the electrophilic O2 attacks the enediolate intermediate, generating a peroxide
intermediate, which then fragments into phosphoglycolate and D-3-phosphoglycerate. The
net reaction is
(3)
There is no carbon gain (i.e., 5C → 2C + 3C). These and other reactions catalyzed by wild-
type and mutant forms of Rubisco are discussed in more detail by Schloss and Hixon (13).
Although the oxygenase reaction of Rubisco may be regarded as a side reaction, the
maximal oxygenase rate at atmospheric levels of O2 and CO2 may reach about 50% of the
CO2 fixation rate (13). Because the ratio of CO2/O2 utilization varies markedly among CO2-
fixing higher plants, algae, and cyanobacteria, much effort has been devoted to
understanding the topology of the active site that controls the CO2/O2 utilization ratio in the
various Rubisco enzymes (14). It has been hoped by some that by suitable molecular
engineering, the CO2/O2 utilization ratio in Rubisco of commercially important crops may
be increased. If successful, the increased biomass yields would be of enormous benefit to the
burgeoning human population (12). At the present time, however, it appears to be
extraordinary difficult, if not impossible, to divorce the O2-consuming reaction of Rubisco
from its CO2-consuming reaction.
Possibly, the oxygenase reaction catalyzed by Rubisco has an important physiological role
in its own right and was therefore not eliminated during evolution. Remarkably, the
intermediate peroxide in this reaction does not leave the active site, there is no release of
reactive oxygen species (ROS), and O2 is consumed. Therefore, the oxygenase reaction
catalyzed by Rubisco may be a mechanism to lower the concentration of potentially harmful
O2. However, many other enzyme-catalyzed oxidative side reactions may on occasion be at
best neutral, or at worst detrimental. Indeed, we suggest later that such side reactions may
play roles in cancer and neurodegenerative diseases. As we discuss below, it is likely that
even relatively slow oxidative side reactions may be physiologically important in some
cases. Thus, although we use the term side reaction liberally here, it should be borne in mind
that such reactions are not necessarily merely enzymological curiosities and may have
biological and clinical relevance.
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IV. Reaction of Carbanions with Oxygen Catalyzed by Selected Enzymes
(Excluding Pyridoxal 5′-Phosphate–Containing Enzymes)
A. BACKGROUND
By the early 1990s it was well known that Rubisco catalyzes an oxygenase side reaction and
that several enzymes catalyze the transfer of electrons from substrate to artificial oxidants.
However, the full extent to which carbanion-forming enzymes catalyze side reactions
directing the transfer of electrons from substrate to ambient O2 was not appreciated at that
time. In 1991, Abell and Schloss pointed out that any enzyme that generates a carbanionic
intermediate is theoretically capable of reacting not only with electrophiles (oxidants) other
than O2 but also with O2 itself (15). Accordingly, these authors investigated several
enzymes that catalyze reactions in which carbanionic species are intermediates for their
ability to catalyze oxygenase/oxidase side reactions. Carbanion-generating enzymes reported
to catalyze oxygenase/oxidase side reactions included Salmonella typhimurium acetolactate
synthase isozyme II (ALS II), brewer's yeast PDC, Escherichia coli glutamate decarboxylase
(GAD), Staphylococcus aureus fructose 1,6-bisphosphate aldolase, and E. coli L-rhamnulose
1-phosphate aldolase (15–17). On the other hand, no oxygenase/oxidase side reactions could
be detected for several other carbanion-forming enzymes, including rabbit muscle fructose
1,6-bisphosphate aldolase, E. coli [(phosphoribosyl)amino]imidazole carboxylase, Torula
yeast 6-phosphogluconate dehydrogenase, pig heart isocitrate dehydrogenase (NADP+),
baker's yeast triose phosphate isomerase, and E. coli L-fuculose 1-phosphate aldolase (15–
17).
Four well-studied examples of enzymes that catalyze a paracatalytic side reaction with
molecular O2 are discussed in detail below. Two of these enzymes (ALS II and PDC) are
thiamine diphosphate (ThDP)-dependent. The third and fourth examples are fructose-1,6-
bisphosphate aldolase and L-rhamnulose-1-phosphate aldolase. These aldolases do not
contain an organic cofactor. Several pyridoxal 5′-phosphate (PLP)–containing enzymes that
catalyze paracatalytic reactions with O2 are discussed in Section V. The α-ketoglutarate
dehydrogenase complex (KGDHC), which contains ThDP in one of its component enzymes,
catalyzes paracatalytic reactions with electron acceptors. Under certain circumstances,
KGDHC also catalyzes the formation of O2˙− (dismutating to H2O2). Because of the likely
biological importance of these reactions catalyzed by KGDHC, they are discussed separately
(Sections VII and VIIIC).
B. ACETOLACTATE SYNTHASE
ALSs are enzymes that catalyze important steps in the biosynthetic pathway to the branched-
chain amino acids (18). When two equivalents of pyruvate are used as a substrate pair, the
product is acetolactate: a precursor of valine and leucine:
(4)
On the other hand, when pyruvate and α-ketobutyrate are used as a substrate pair, the
product is α-aceto-α-hydroxybutyrate:
(5)
Hence, the alternative name for ALS is acetohydroxy acid synthase (AHAS). α-Aceto-α-
hydroxybutyrate is a precursor of isoleucine.
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As noted above, ALS II catalyzes a paracatalytic side reaction with O2. The ultimate product
of the reaction is acetate. The mechanism of the reaction catalyzed by S. typhimurium ALS
II has been studied extensively. The enzyme contains both flavin adenine dinucleotide
(FAD) and ThDP within the active site. 4,5-Deaza-FAD (a substitute for FAD that is not
competent for one-electron chemistry) and added superoxide dismutase had no effect on O2
consumption, indicating that the FAD in the active site and adventitious metal ions do not
play a role in the oxygenase reaction [(15); see also below]. These data, together with the
labeling patterns obtained with 18O2, [2-13C]pyruvate, and H2 182O were consistent with the
oxygenase reaction:
(6)
in which FAD plays mostly a structural role (15).
Taken together, the data suggested that a (hydroxyethyl)thiamine diphosphate
hydroperoxide intermediate is converted to peracetate [CH3C(O)O2−] and ThDP [reaction
(6)]; the peracetate then reacts with one equivalent of pyruvate, forming two equivalents of
acetate (19):
(7)
The 2 : 1 stoichiometry between acetate produced and O2 consumed was confirmed in
careful labeling studies with [18O]O2 (15, 19). In the normal condensation reaction, the
second pyruvate (or α-ketobutyrate) competes with O2 for reaction with a common
intermediate (20). It was noted that the enzyme was eventually inactivated by the products
of the reaction (15). This inactivation is presumably paracatalytic, as noted previously, for
example, with rabbit muscle fructose 1,6-bisphosphate aldolase during trapping experiments
with the external oxidant hexacyanoferrate(III) (21).
Note that the product of the oxygenase reaction catalyzed by S. typhimurium ALS II has one
less carbon than in the substrate (pyruvate). There is no H2O2 produced from the peroxide
intermediate in the oxygenase side reaction catalyzed by ALS II [reaction (6)], although a
peracid is produced as an intermediate. This situation is similar to that observed for the
oxygenase reaction catalyzed by Rubisco, where no H2O2 is produced [reaction (3)].
S. typhimurium ALS II was previously reported to either reduce the enzyme-bound FAD or
to support attack of the carbanionic intermediate on the isoalloxazine ring of the flavin (22,
23). Recently, it was proposed that E. coli ALS II (AHAS) transfers electrons to the
enzyme-bound FAD (i.e., reduces the flavin) and produces H2O2 as one of the products of
the O2-consuming reaction (24). However, no evidence was provided for H2O2 production.
Further, as noted above, S. typhimurium ALS II does not produce H2O2 under aerobic
conditions (15, 25), but does produce per-acetate (25). ALS II (ilvG) is thought to have
evolved from pyruvate oxidase (poxB) or from a common ancestor that used the tightly
bound FAD cofactor to convert pyruvate and O2 to acetate, CO2, and H2O2 (26). Rather
than reducing O2 to H2O2, pyruvate oxidase transfers electrons in vivo to a lipophilic
quinone (Q10).
A number of commercial herbicides, exemplified by sulfonylureas and imidazolinones, are
thought to bind to the evolutionary vestige of the quinone-binding site in ALS (27).
Consistent with this notion, water-soluble quinones (Q0 and Q1) compete with these
herbicides for binding to ALS II and can reversibly inhibit the enzyme in a noncompetitive
fashion with respect to pyruvate (27). Similar to the binding of quinones to pyruvate
oxidase, the herbicides bind most tightly to ALS II after addition of pyruvate (27). In
BUNIK et al. Page 5













contrast to pyruvate oxidase, however, S. typhimurium ALS II does not reduce Q0 in the
presence of pyruvate (23). On the other hand, if FAD at the active site of ALS II is
photoreduced, the enzyme is able to reduce Q0. However, the enzyme does not catalyze this
reaction. Half of the enzyme-bound photoreduced flavin is oxidized by Q0 at a rate similar
to the rate at which free FAD is oxidized by Q0 (>108 M−1 s−1). The other half of the
enzyme-bound photoreduced flavin is oxidized more slowly (28,200 M−1 s−1) (23).
These data suggest that the flavin quenching observed for E. coli ALS II (24) and S.
typhimurium ALS II (22, 23) is not due to a reduction of the flavin to FADH2, but rather to
a reversible attack of the carbanion on the flavin isoalloxazine ring. Furthermore, ALS II,
which has been stripped of its tightly bound flavin and reconstituted with FAD, no longer
exhibits quenching of flavin absorbance upon addition of pyruvate (28). Substitution of FAD
with flavins that are incompetent for one electron transfer (e.g., 8-demethyl-8-chloro-FAD,
5-deaza-5-carba-FAD, or 8-demethyl-8-hydroxy-5-deaza-5-carba-FAD) produces a
catalytically competent ALS II, exhibiting 84, 100, or 57% specific activity, respectively,
relative to that of enzyme containing FAD (23). Similarly, substitution of the FAD in the
active sites of ALS I or ALS III (two additional isozymes of ALS) with 8-demethyl-8-
hydroxy-5-deaza-5-carba-FAD has only modest effects on the specific activity of their
synthase reactions [2 pyruvates → acetolactate + CO2; reaction (4)], exhibiting 98 and 39%
specific activity, respectively, relative to that of enzyme containing FAD (23). By contrast,
substitution of the FAD in pyruvate oxidase with 8-demethyl-8-hydroxy-5-deaza-5-carba-
FAD results in a catalytically incompetent enzyme (<2% activity) (23).
The accumulated evidence strongly suggests that O2 reacts directly with the carbanionic
intermediate (radical form) generated by the ALS II–catalyzed decarboxylation of pyruvate.
The commercial herbicides that inhibit ALS II (e.g., sulfometuron methyl, a sulfonylurea)
trap an O2-sensitive reaction intermediate on the enzyme, thereby inducing paracatalytic
inactivation of the enzyme by O2 (29). The structures of several ALS–sulfonylurea
complexes have been reported (18, 30–32). The crystal structures and structures deduced by
homology modeling are consistent with the herbicides closing the active site. Paracatalytic
inactivation of ALS, induced by interaction with commercial herbicides, is an important
aspect that dramatically enhances herbicidal activity at the level of the whole plant. The
peracetate produced in the oxygenase reaction of ALS II is a highly reactive oxidant which
will react readily with thiols (6000 M−1 s−1), pyruvate (20 M−1 s−1), and various assay
components (e.g., buffers, cofactors, and other enzymes) (25, 33). Peracetate also reacts with
various metals, such as Co2+ (2000 M−1 s−1), Mn2+, Pb2+, and Fe3+, to produce molecular
O2, light, and other products (e.g., CO2 and methane) (13, 19, 25, 33). The light produced by
peracetate is likely to be a consequence of radiation produced by an activated metal, as it
does not have the proper spectral characteristics to be produced by decay of singlet oxygen
to its triplet state (13, 19, 25).
C. PYRUVATE DECARBOXYLASE
Yeast PDC, which catalyzes the decarboxylation of pyruvate to acetaldehyde, utilizes ThDP
as a cofactor. The enzyme catalyzes formation of the same (hydroxyethyl)thiamine
diphosphate intermediate as ALS II, but lacks the flavin in the active site (15, 25). This
enzyme was shown to catalyze an oxygenase side reaction, the end product of which is
acetate (15, 25). The reaction proceeds through the oxidation of pyruvate with peracetate as
shown for ALS II [reactions (6) and (7)]. The corresponding PDC from Zymomonas mobilis
supports a somewhat higher level of oxygenase activity than the yeast enzyme (25). The Z.
mobilis PDC oxygenase activity is about twice that of yeast PDC in the presence of 50 mM
2-(N-morpholino)ethanesulfonic acid (MES)–NaOH (pH 6.0), 10 mM MgCl2, 0.1 mM
ThDP, and 25 mM sodium pyruvate (33 versus 16 nmol min−1 mg−1, respectively) (25).
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Yeast PDC, Z. mobilis PDC, and ALS II were confirmed to produce a peracid as their initial
oxygenase product by relying on the more rapid interaction of peracetate with 5-
thionitrobenzoate (TNB) than with pyruvate (25). By using TNB, a continuous assay for the
formation of peracetate was devised for both ALS II and the Z. mobilis PDC. The activity of
this assay was dependent on the respective substrate and O2. This assay could also
distinguish between the production of H2O2 and peracetate, due to the much greater
reactivity of peracetate toward TNB (25). Under the conditions used for assay of ALS II, for
example, TNB reacted about 3000 times faster with peracetate (6000 M−1 s−1) than with
H2O2 (2 M−1 s−1).
D. ALDOLASES
S. aureus fructose 1,6-bisphosphate aldolase is a class I aldolase. Class I aldolases do not
require a cofactor but make use of Schiff-base chemistry involving a lysine residue during
the catalytic cycle. S. aureus fructose 1,6-bisphosphate aldolase catalyzes the slow uptake of
O2 in the presence of substrate (15). For every equivalent of O2 taken up, 0.25 equivalent of
hydroxypyruvaldehyde phosphate and 0.25 equivalent of 3-phosphoglycerate are generated.
Evidently, the hydroperoxide formed from the carbanionic intermediate (1,3-
dihydroxyacetone phosphate, enolate form) plus O2:
(8)
can break down to form either hydroxypyruvaldehyde phosphate and H2O2:
(9)
or 3-phosphoglycerate and H2O2:
(10)
Interestingly, the enzyme undergoes inactivation during the course of the reaction (15). It
should be pointed out that hydroxypyruvaldehyde phosphate in the form of its hydrate (gem-
diol) can isomerize to 3-phosphoglycerate under alkaline conditions (19).
In later work, the ability of two metal-containing class II aldolases to catalyze oxygenase-
type side reactions was investigated (16, 17). It was found that E. coli L-rhamnulose 1-
phosphate aldolase catalyzes an O2-consuming side reaction. In a fashion similar to Rubisco,
this enzyme catalyzes the formation of an ene-diolate intermediate. However, the Rubisco
oxygenase reaction is unlike that of L-rhamnulose 1-phosphate aldolase, in that the former
reaction results in scission of the intermediate with no production of H2O2 [reaction (3)],
whereas in the side reaction catalyzed by L-rhamnulose 1-phosphate aldolase, H2O2 is
generated in amounts roughly stoichiometric with O2 consumption (16).
Unlike E. coli L-rhamnulose 1-phosphate aldolase, E. coli L-fuculose 1-phosphate aldolase is
unable to support an oxygenase/oxidase side reaction (16). Despite limited sequence
homology, L-rhamnulose 1-phosphate aldolase and L-fuculose 1-phosphate aldolase are
structurally and mechanistically similar (34–36). Thus, some carbanion-forming enzymes
have evolved the ability to either fully protect intermediates from attack by O2 whereas
others have not (15) or have substantially more radical-forming character than others have
(13).
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The question arises as to why some carbanion-forming enzymes catalyze oxygenase/oxidase
side reactions, whereas others do not. In the absence of stabilizing factors, any peroxide
intermediate formed between carbanion and O2 could decompose back to carbanion and O2.
Stabilizing factors could include protonation of the peroxide anion and/or metal coordination
(15). These factors may differ even within conserved active sites in closely related enzymes,
due to variations in the conformational mobility of the protein. For example, the difference
observed in the oxygenase activity between yeast PDC and Z. mobilis PDC may correlate
with differences in the role of conformational changes in regulation of the enzymes.
Whereas the yeast enzyme is subject to allosteric activation by pyruvate, the Z. mobilis
enzyme is not (37).
It is interesting to note that a metal cofactor is not an absolute requirement for an enzyme to
catalyze a side reaction with molecular O2. For example, S. aureus fructose 1,6-bisphosphate
aldolase, but not the rabbit muscle fructose 1,6-bisphosphate aldolase, catalyzes an
oxygenase side reaction (15). Although the former enzyme was initially misidentified as a
class II (metal-dependent) aldolase (15–17), neither of these enzymes possesses a metal
cofactor. Thus, with S. aureus fructose 1,6-bisphosphate aldolase and rabbit muscle fructose
1,6-bisphosphate aldolase, the difference in reactivity toward molecular O2 is not related to
the presence of metal cofactor.
Nevertheless, in other cases a metal cofactor may be essential for an enzyme to carry out
side reactions with molecular O2. For example, both L-rhamnulose 1-phosphate aldolase and
L-fuculose 1-phosphate aldolase contain Zn2+ as a cofactor. The substrates for these two
enzymes are epimeric at a single position, and both enzymes catalyze similar reactions (35,
36). However, as noted above, only the former enzyme catalyzes an oxidase reaction.
Interestingly, L-rhamnulose 1-phosphate aldolase has substantially greater oxidase activity
with Co2+ or Mn2+ as the activating metal than with the natural cofactor Zn2+. Similar to the
oxygenase activity of the Rhodospirillum rubrum Rubisco, where replacement of active site
Mg2+ with Co2+ results in an enzyme with exclusive oxygenase activity (38), various metals
support different relative levels of oxidase activities with the rhamnulose 1-phosphate
aldolase. Although different metal ions cause different relative amounts of “normal” versus
oxidase/oxygenase activities for both rhamnulose 1-phosphate aldolase and Rubisco, the
rank order in which metals support these two activities varies. Moreover, substitution of
various metals for Mg2+ in the oxygenase reaction of ALS II has only a modest effect on the
relative levels of synthase and oxygenase activity (20). Clearly, the relative oxygenase/
oxidase activities are not solely a feature of the activating metal ion, but also depend on the
structure of the active site.
A summary of the carbanion-generating enzymes (excluding PLP-containing enzymes)
currently known to catalyze oxygenase/oxidase side reactions is given in Table 1.
V. Oxidation Reactions Catalyzed by PLP-Containing Amino Acid
Decarboxylases
A. BACKGROUND
Healy and Christen in 1973 described the first paracatalytic reaction catalyzed by a PLP-
dependent enzyme (2). These authors showed that in the presence of the amino acid
substrate analog D,L-erythro-β-hydroxy aspartate, cytosolic pig heart aspartate
aminotransferase catalyzes reduction of the artificial electron acceptor (oxidant)
hexacyanoferrate(III). No enzyme-catalyzed reduction was observed in the absence of amino
acid (2). At that time, however, no PLP-containing enzyme was known to interact
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paracatalytically with O2. Subsequently, several PLP-dependent decarboxylases were shown
to react directly with O2, and these enzymes are described individually below. In three cases
[glutamate decarboxylase (GAD), dopa decarboxylase (DDC), ornithine decarboxylase
(ODC)], the enzyme-catalyzed oxidative reaction with O2 is slower than the enzyme-
catalyzed “natural” nonoxidative decarboxylation reaction. However, in one case
[phenylacetaldehyde synthase (PAAS)], evolutionary pressure has converted an ancestral
decarboxylase that presumably catalyzed a nonoxidative amino acid decarboxylation to an
enzyme that catalyzes the stoichiometric oxidative decarboxylation of its amino acid
substrate. The considerations above raise the intriguing question of why PLP-dependent
decarboxylases, among the many disparate classes of PLP-containing enzymes, are
apparently unique in their ability to catalyze paracatalytic reactions with O2.
B. GLUTAMATE DECARBOXYLASE
E. coli GAD catalyzes O2 uptake in the presence of glutamate (15). The nonoxidative and




respectively. Bertoldi et al. showed that E. coli GAD oxidizes α-methyl-L-glutamate to
ammonium and levulinate. Only half an equivalent of O2 was shown to be consumed for
every equivalent of ammonium and levulinate produced; no H2O2 was detected (39):
(13)
Bertoldi et al. stated that GABA is also an oxygenase substrate of E. coli GAD (39). Since
other authors reported that this enzyme could not support an oxidation reaction with GABA
(15, 40), the level of oxidase activity with GABA must be quite low.
More recent work has established that the E. coli GAD oxidase reaction has a rapid
equilibrium ordered kinetic mechanism in which O2 traps glutamate in a ternary complex
with enzyme that turns over to products very slowly (40). Partitioning between the “normal”
GABA-forming reaction and the oxidase reaction is shifted dramatically in 2H2O relative to
that in 1H2O. The addition rate of O2 (kcat/Km oxygen) and the fraction of glutamate
converted to oxidase-specific products (H2O2, ammonium, and succinic semialdehyde) are
approximately 10-fold greater in 2H2O than in 1H2O. This appears to be a consequence,
under steady-state conditions, of a larger fraction of the enzyme intermediate being present
as a radical form in 2H2O than in 1H2O. It is the radical intermediate that reacts with O2.
The recombinant isozymes of human GAD that are either GABA-vesicle associated
(GAD65) or localized in the cytosol (GAD67) are sensitive to reversible inhibition by
molecular O2 or by nitric oxide (NO) under anaerobic conditions (41). Two other PLP-
dependent decarboxylases, that is, two isozymes of porcine cysteine sulfinic acid
decarboxylase (CSAD I and CSAD II), are also sensitive to reversible inhibition by O2 and
NO (41). Unlike molecular O2, which is a biradical (i.e., contains two unpaired electrons),
NO has only a single unpaired electron. It is important to specify that experiments with NO
were conducted in the absence of O2, since NO will react rapidly with O2 to form other
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products. NO is known to bind to various paramagnetic substances and is a commonly used
paramagnetic probe.
E. coli GAD, recombinant human GAD65, recombinant human GAD67, recombinant
porcine CSAD I, and recombinant porcine CSAD II are remarkably similar with respect to
their sensitivity to reversible inhibition by O2 (KI=0.2 to 0.5 mM) or NO (KI=0.2 to 0.5
mM) (41). However, the inhibition does not reflect the ability of the enzymes to use O2 as a
substrate. (The ability of porcine CSAD I and CSAD II to catalyze an oxidative
decarboxylation reaction has not been studied.) Human GAD65 does not consume O2 (as
assessed with an O2 electrode) or produce H2O2 (as assessed by the glutathione–glutathione
peroxidase coupled reaction) at levels comparable to those observed for the E. coli enzyme
(42). Also, the rate at which the E. coli enzyme utilizes O2 in the H2O2/NH4+/succinic
semialdehyde-forming reaction [reaction (12)] is disproportionate to the effect that O2 has
on the GABA-forming reaction (41). Under normal atmospheric conditions, the oxidase
reaction catalyzed by E. coli GAD proceeds at approximately 0.2% of the rate of the GABA-
forming reaction. However, under the same conditions, O2 inhibits the GABA-forming
reaction by 30% relative to the reaction rate observed under anaerobic conditions. In the
presence of 1 atm of pure O2, the GABA-forming reaction is inhibited by 70%. However,
under these conditions, the rate of the oxidase reaction is 1.2% of the rate of the GABA-
forming reaction.
Clearly, there is more O2-induced inhibition of the GABA-forming reaction than can be
accounted for by diversion of glutamate into the oxidase reaction. Inhibition of the GABA-
forming reaction correlates with saturation of the H2O2/succinic semialdehyde/NH4+-
forming reaction. Oxygen (Km=0.56 mM) traps glutamate (KIA=13 mM) into a complex that
turns over to products (H2O2, succinic semialdehyde, and NH4+) very slowly (0.9 min−1).
Although the complex formed between O2 and human GAD65 does not turn over at a rate
comparable to that of E. coli GAD, the rate of O2 release is likely to be similar, since the
amount of inhibition (uncompetitive, KII=0.2 mM) of the GABA-forming reaction by O2 is
comparable. In the presence of O2, GAD should exhibit slow binding kinetics, due to the
slow rate of O2 release (t1/2=0.8 min). [See the article by Schloss (43) for a discussion of
slow-binding enzyme inhibition and its relationship to reaction-intermediate analogs.]
Further, assuming that O2 actually binds rapidly to the radical enzyme form that is O2
sensitive, the abundance of the radical form can be estimated. In 1H2O, kcat/Km for O2 is 27
M−1 s−1 and increases to 175 M−1 s−1 in 2H2O (40). If O2 actually binds to the radical at a
diffusion-limited rate [about 2.5×109 M−1 s−1 (13)], only 0.000001% of the enzyme exists in
a radical form in steady state. The fraction of GAD existing as a radical in steady state
would increase to 0.000007% in 2H2O.
Unlike the E. coli GAD, human GAD65 is inactivated under aerobic assay conditions in the
absence of various thiols. This has precluded the same type of detailed kinetic analysis of
human GAD65 that has recently been completed for E. coli GAD. Attempts to determine
whether human GAD65 can support an oxidase reaction under any conditions, similar to E.
coli GAD, have met with mixed results (42). However, it has been reported that pig brain
GAD produces succinic semialdehyde in the presence of glutamate, with concomitant
inactivation of the enzyme by transamination of the PLP cofactor to PMP (44). A similar
inactivation of pig brain GAD by aspartate has also been reported (45). It is unclear whether
the inactivation of pig brain GAD by transamination is in addition to and independent of
interaction of the enzyme with O2 or whether this may also be an O2-dependent process.
However, inhibition of human GAD65 by O2, which would interfere with loading of GABA
vesicles and GABAergic synaptic function in the brain, is likely to be responsible for O2-
induced seizures (41) (see also Section XIII). Under conditions of hyperbaric oxygen, an
unusual cyclic change in the concentration of GAD67 (cytoplasmic GAD), but not in
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GAD65 (GABA vesicle-bound GAD), has been observed (46). Presumably, this cyclic
change in the intracellular level of GAD67 is related to the reversible inhibition of GAD by
oxygen, since there was no irreversible loss of either GAD65 or GAD67 during the period of
observation.
C. DOPA DECARBOXYLASE
Bertoldi et al. showed that native pig kidney DDC catalyzes oxidation of aromatic amines
(39, 47–53). The pig kidney DDC-catalyzed conversion of L-dopa to dopamine and L-5-
hydroxytryptophan to serotonin, however, is about 100 times faster than the enzyme-
catalyzed conversion of dopamine to 3,4-dihydroxyphenylacetaldehyde and serotonin to 5-
hydroxyindoleacetaldehyde, respectively (51). Ammonium production from the amine is
stoichiometric with aldehyde formation and with consumption of half an equivalent of O2.
In initial reports, no H2O2 formation was detected (51). However, more recently the
production of both H2O2 and superoxide was inferred, based on the slower rate of oxygen
consumption observed in the presence of catalase or superoxide dismutase (53). The
nonoxidative decarboxylation of aromatic amino acids is shown as:
(14)
Oxidation of the corresponding amines apparently proceeds with the stoichiometry:
(15)
Presumably, the oxygen or superoxide produced in the first round of catalysis is consumed
as a substrate in a second round of catalysis (53).
Earlier reports that pig kidney DDC catalyzes an abortive half-transamination with L-dopa
under aerobic conditions (54) may require reinterpretation, since it appears that abortive
transamination competes with the oxygen-consuming reaction, depending on the availability
of O2 or other oxidants (e.g., H2O2 or superoxide) (51, 53). Nevertheless, pig kidney DDC
can catalyze half-transamination reactions with (1) B-aromatic amino acids under aerobic
conditions, (2) with L-aromatic amino acids, B-aromatic amino acids, and aromatic amines
under anaerobic conditions, and (3) α-methyl L-dopa under aerobic conditions (48, 51, 53).
With α-methyl L-dopa, the product of oxidative decarboxylation is 3,4-
dihydroxyphenylacetone (39, 48, 51, 53):
(16)
The partitioning ratio between oxidative decarboxylation and abortive transamination with
this substrate is about 100 (51). The oxidized products generated from serotonin (47) and
dopamine (51) eventually cause inactivation of the enzyme by covalent modifications of the
enzyme/cofactor. Thus, molecular O2 seems to play a role as substrate and as an enzyme
regulator.
Bertoldi et al. showed that mutation of tyrosine 332 to phenylalanine converts pig kidney
DDC to a decarboxylation-dependent deaminase, in which decarboxylation of amino acid is
stoichiometric with oxidation (50, 53). Unlike the reaction catalyzed by the native enzyme,
the amine product cannot be detected in the reaction catalyzed by the mutated enzyme.
However, under aerobic conditions, both native and mutated enzymes catalyze oxidation of
dopamine at about the same rate. Under anaerobic conditions, the mutated enzyme
exclusively catalyzes a decarboxylation-dependent half-transamination (50, 53).
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Several cases of dopa decarboxylase deficiency have been reported [reviewed by Allen et al.
(55)]. The defect is inherited in an autosomal recessive fashion. Although rare, it is
suggested that the incidence might be underreported. Activity may be low to undetectable.
Some patients, although not all, are helped by treatment with a monoamine oxidase
inhibitor, dopamine antagonist, and pyridoxine. In those patients helped by pyridoxine it is
possible that the mutation results in less effective binding of PLP in the active site. Since, as
noted above, a relatively conservative change in a tyrosine residue to a phenylalanine
residue at the active site converts DDC to an oxidative decarboxylase, it would be
interesting to determine whether mutations of DDC that have arisen naturally in the human
population may enhance oxidation reactions at the expense of nonoxidative decarboxylation.
D. ORNITHINE DECARBOXYLASE
Bertoldi et al. showed that ODC prepared from Lactobacillus 30a catalyzes the oxidative
deamination/decarboxylation of L-α-methylornithine (39). The product of the reaction was
identified as 2-methyl-Δ1-pyrroline, which arises through cyclization/dehydration of the
corresponding aldehyde (5-aminopentan-2-one). One equivalent of ammonium was
generated at the expense of half an equivalent of O2 consumed (39). The decarboxylation
reaction with L-ornithine is:
(17)
and the oxidative decarboxylation of α-methyl-L-ornithine is:
(18)
The authors also found that putrescine is oxidatively deaminated by Lactobacillus ODC at a
relatively slow rate. Half an equivalent of O2 was consumed per equivalent of putrescine
oxidized (39).
The Lactobacillus ODC was shown to catalyze a half-transamination reaction with α-
methyl-L-ornithine (39). The partition ratio between oxidative deamination and half-
transamination with this substrate was 12 : 1 (39). The Lactobacillus ODC is therefore
remarkably similar to the E. coli GAD in its ability to oxidatively deaminate/decarboxylate
α-methyl amino acid substrates and to catalyze a low-efficiency half-transamination of PLP
with α-methyl amino acid substrate (39).
In earlier work (56), Sakai et al. showed that an ODC purified from Hafnia alvei catalyzes
the oxidative decarboxylation of L-ornithine to 4-aminobutanal:
(19)
which reversibly cyclizes and dehydrates nonenzymatically to Δ1-pyrroline (not shown).
The authors named this activity L-ornithine oxidase (decarboxylating) (OOD). Most turnover
events at the active site lead to the release of CO2 and to the formation of putrescine
[reaction (17)]. Occasionally (about one turnover in 160), however, the enzyme converts L-
ornithine and O2 to 4-aminobutanal [reaction (19)]. Unlike DDC, which can oxidize
dopamine (the end product of the nonoxidative decarboxylation of substrate L-dopa), ODC/
OOD could not be shown to oxidize putrescine (the end product of the nonoxidative
decarboxylation of substrate L-ornithine) (56).
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Recent work has shown that petunia petal PAAS oxidatively converts L-phenylalanine
stoichiometrically to phenylacetaldehyde, ammonium, H2O2, and CO2 (57):
(20)
Phenylethylamine is neither a product nor a substrate (57). PAAS also converts α-methyl-L-
phenylalanine to phenylacetone:
(21)
In the presence of catalase, the enzyme can catalyze turnover of phenylalanine to
phenylacetaldehyde for several hours without loss of activity. Interestingly, however, in the
absence of catalase to trap H2O2, PAAS is slowly inactivated (57).
As noted above, native pig kidney DDC catalyzes the nonoxidative decarboxylation of dopa
to dopamine. However, mutation of an active-site tyrosine residue to a phenylalanine
converts pig kidney DDC to an enzyme that stoichiometrically catalyzes an oxidative
decarboxylation of dopa to an aromatic aldehyde (50, 53). It is interesting to note that during
evolution the corresponding residue in the ancestral dopa-decarboxylase-like enzyme was
converted from a tyrosine to a phenylalanine in the case of rose PAAS and to a valine in the
case of petunia PAAS (57).
An interesting analogous reaction to that catalyzed by PAAS has recently been described in
which N-hydroxy-L-phenylalanine is oxidatively decarboxylated to Z-phenylacetaldoxime.
The enzyme that catalyzes this reaction, tentatively named N-hydroxy-L-phenylalanine
decarboxylase/oxidase, was isolated from a Bacillus strain and shown to contain only PLP
as a cofactor (58). Although not measured, it is probable that H2O2 is generated in the
reaction.
VI. Mechanisms Contributing to the Oxidation Reactions Catalyzed by PLP-
Containing Amino Acid Decarboxylases
The oxidation reactions catalyzed by various PLP-containing decarboxylases are shown in
Table 2. E. coli GAD, H. alvei ODC, and petunia PAAS catalyze the oxidative
decarboxylation of their respective amino acid substrates to aldehydes, ammonium, and CO2
with the stoichiometric production of H2O2. Oxygen in the aldehyde moiety of the product
is derived from water. These enzymes, therefore, clearly meet the definition of oxidases. In
the case of the petunia PAAS reaction, net oxidation is stoichiometric with decarboxylation.
However, in the case of the E. coli GAD or H. alvei ODC, oxidative decarboxylation occurs
only about once in every 500 or 160 turnovers, respectively, under normal atmospheric
conditions (0.24 mM dissolved O2; under 21% oxygen at 1 atm).
The putative mechanism by which petunia PAAS catalyzes the oxidative decarboxylation of
phenylalanine is shown in Figure 1. We suggest that PAAS catalyzes a biradical mechanism
similar to that proposed for E. coli GAD (41). There are many possible radical mechanisms
that could be written for this reaction. Normally, even for reactions that are commonly
accepted to involve radical intermediates, such as those involving the isoalloxazine ring of
flavin cofactors, the radical intermediates are not shown. This is because, in most cases,
radical forms are short-lived, high-energy intermediates, which are usually difficult to
observe directly, due to their low abundance in the steady state. However, in the
hypothetical reaction sequence illustrated in Figure 1, radical intermediates are included for
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purposes of illustration only. These are not the only possible radical forms, nor are they
likely to build up to detectable levels during steady state. The following mechanistic steps
include those commonly accepted for PLP-dependent enzymes and additional steps unique
to the oxygen-utilizing reactions. In the absence of substrate, the PLP coenzyme forms a
Schiff base with the ε-amino group of a lysine residue at the enzyme active site (E-PLP
aldimine). Binding of phenylalanine at the active site leads to formation of a new Schiff base
(Phe-PLP aldimine) in which the α-amino group of phenylalanine (Phe) displaces the ε-
amino group of the active site lysine. The double bond of the imine is converted from a
singlet state (paired electrons) to a triplet state (unpaired electrons) (biradical intermediate
1). Subsequent decarboxylation generates biradical intermediate 2. Since O2 is a biradical, it
should react extremely rapidly with biradical intermediate 2. Addition of O2 could
theoretically occur at either of the two unpaired electrons of the biradical 2 intermediate
(41). Here we show the addition of O2 at the aldehyde carbon of the intermediate, generating
biradical intermediate 3. Transfer of an electron from the nitrogen base to the peroxy radical
of biradical intermediate 3 will generate a zwitterionic structure containing a peroxy anion
and a radical cation (biradical intermediate 4). This zwitterionic structure is expected to be
short-lived, producing a hydroperoxy intermediate. Reaction of the ε-amino group of a
lysine residue in the active site will generate the E-PLP aldimine with the liberation of 1-
peroxy-2-phenylethylamine, which undergoes nonenzymatic elimination of H2O2 with the
formation of 2-phenylethylimine. Hydrolysis of the imine will yield phenylacetaldehyde and
ammonium. Generation of a biradical form of ribulose 1,5-bisphosphate from an ene-diol
intermediate has been proposed as part of the oxygenase reaction of Rubisco (13). Quantum
mechanical calculations have indicated that the energy level of the radical intermediate can
be reduced substantially by appropriate adjustment of the molecular geometry (59–61).
Since the PLP-imine and other PLP intermediates, especially the quinonoid intermediate,
more closely resemble the structure of the flavin isoalloxazine ring, it is likely that these
radical intermediates will be even lower in energy than those in the oxygenase reaction
catalyzed by Rubisco.
The oxidative decarboxylation reactions catalyzed by E. coli GAD and H. alvei ODC
presumably occur via a radical mechanism similar to that depicted in Figure 1 for petunia
PAAS. However, there are differences among the three enzymes. Petunia PAAS has evolved
to ensure maximal oxidation of substrate intermediate, so that the oxidation is stoichiometric
with decarboxylation. On the other hand, the other two enzymes have either evolved to
exclude O2 from the active site or to reduce the steady-state levels of radical intermediates
available for reaction with O2. Whichever method is employed, the oxidase reaction is not
totally eliminated, since the oxidative decarboxylation reaction still occurs at 0.2 and 0.6%
of the nonoxidative reaction rates, respectively. It will be interesting to compare the active
sites of these enzymes to determine those steric factors that may exclude O2 from the active
site or that affect the steady-state levels of radical intermediates.
PAAS, E. coli GAD, and H. alvei ODC clearly catalyze oxidase reactions as O2
consumption in the presence of L-amino acid substrate is stoichiometrically coupled to
ammonium and H2O2 production. However, the situation with the pig kidney DDC is less
clear. As noted above, in the oxidation reactions catalyzed by DDC, H2O2 cannot be
detected directly and only half an equivalent of O2 is consumed per equivalent of substrate
oxidized. There are several possible explanations for this observation. If DDC were to utilize
H2O2 produced in one round of catalysis as an oxidant in a second round of oxidation, two
equivalents of aldehyde or ketone would be produced for each equivalent of oxygen
consumed. In this explanation, H2O2 would be expected to serve as a substrate for the
oxidation reaction. Such an explanation could be consistent with the recent observation that
the rate of oxygen consumption by DDC is reduced in the presence of catalase or superoxide
dismutase (53). To the best of our knowledge, H2O2 has not been tested as an alternative
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substrate for any of the pig kidney DDC oxygen-consuming reactions. A second possible
explanation for the inability to detect the H2O2 intermediate directly would be that the pig
kidney DDC was prepared by including 0.1 mM dithiothreitol to preserve the enzyme
activity (47). Any thiol present in the assay would effectively prevent detection of H2O2
produced by DDC (25). However, the interference by thiols in assaying for H2O2 would not
explain the 1 : 2 stoichiometry between O2 consumed and aldehyde or ketone produced,
which was observed for DDC (47, 48, 51), Lactobacillus 30a ODC (39), and E. coli GAD
(39). Since a 1 : 1 stoichiometry between O2 consumed and H2O2/aldehyde produced has
been observed by other investigators for one type of bacterial ODC (56), E. coli GAD (15,
40, 41), and PAAS (57), there are clearly problems in the literature that need to be resolved.
Another point of interest is that all the native decarboxylases listed in Table 3, except pig
kidney DDC, can oxidatively decarboxylate their L-amino acid substrates with varying
efficiencies, but cannot effectively oxidize the amine product when this is added directly to
the enzyme. On the other hand, pig kidney DDC can oxidize aromatic amines, but not the L-
amino acid substrate. It would seem, however, that not much perturbation (either of the
active site itself or with a modified substrate) is required to enable pig kidney DDC to
catalyze an oxidative decarboxylation. Thus, as noted above, a Tyr → Phe mutation at
position 322 results in an enzyme that can effectively catalyze oxidative decarboxylation of
dopa. Additionally, the native enzyme can catalyze the oxidative decarboxylation of L-α-
methyldopa (51, 53).
Vitamin B6 in its active form (usually, PLP, but occasionally, PMP) is a remarkably
versatile biological catalyst. Enzyme-catalyzed reactions in which PLP is a cofactor include,
but are not limited to, racemization, transamination, α-decarboxylation, β-decarboxylation,
β-decarboxylation–addition, reverse aldol condensation, α,β-elimination, α,β-replacement,
β,γ-elimination, and β,γ-replacement (62, 63). Most reactions catalyzed by vitamin B6–
containing enzymes are not generally considered to involve radical intermediates. The
mechanism of almost all such enzymes is thought to be based on their ability to stabilize
high-energy anionic intermediates in their reaction pathways by the pyridinium moiety of
PLP/PMP (64). However, a few exceptions are known. One example is Clostridium
subterminale lysine 2,3-aminomutase (65). This enzyme catalyzes the PLP-dependent
interconversion of L-lysine and L-β-lysine. The reaction mechanism includes one-electron
chemistry and uses a [4Fe–4S] cluster and S-adenosylmethionine (65). Another example of a
PLP enzyme that catalyzes a radical mechanism is Clostridium stricklandii lysine 5,6-
aminomutase. This enzyme catalyzes an adenosylcobalamin (vitamin B12)–dependent
interconversion of D-lysine with 2,5-diaminohexanoate and of L-β-lysine with 3,5-
diaminohexanoate (66). A third vitamin B6-dependent enzyme that participates in a radical
mechanism is CDP-6-deoxy-L-threo-D-glycero-4-hexulose-3-dehydrase. This enzyme
catalyzes the C-3 deoxygenation in the biosynthesis of 3,6-dideoxyhexoses in Yersinia
pseudotuberculosis and is a PMP-dependent enzyme that also contains a [2Fe–2S] center
(67).
Based on the findings that several PLP-containing decarboxylases can catalyze oxidations
with O2 as side reactions (and in at least one case an oxidative decarboxylation that is the
predominant pathway), it would seem that the potential for PLP to participate in radical
mechanisms is more widespread than is generally appreciated.
VII. Paracatalytic Oxidation of the α-Ketoglutarate Dehydrogenase–
Generated Carbanion
α-Ketoglutarate dehydrogenase (E1k) is a member of a family of α-keto acid
dehydrogenases that also includes pyruvate dehydrogenase (E1p) and the branched-chain α-
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keto acid dehydrogenase (E1b). The enzymes catalyze the first and rate-controlling steps of
the overall reactions within the α-ketoglutarate dehydrogenase complex (KGDHC),
pyruvate dehydrogenase complex (PDHC), and branched-chain α-keto acid dehydrogenase
complex (BCDHC), respectively. These enzyme complexes are similar in their architecture
and catalytic mechanism. Both PDHC and KGDHC have been shown to catalyze reactions
with external oxidants, which can lead to paracatalytic inactivation. For example, pig heart
PDHC was shown to be paracatalytically inactivated in the presence of [14C]pyruvate,
ThDP, and the oxidant DCIP (68). Inactivation was accompanied by incorporation of
radioactivity into the PDHC complex, mostly into the E2p component (68). However, most
of the work on the paracatalytic reactions of α-keto acid dehydrogenases has been carried
out with KGDHC. Therefore, most of the discussion in this section is devoted to this enzyme
complex.
The α-ketoglutarate dehydrogenase complex (KGDHC) self-assembles from multiple copies
of α-ketoglutarate dehydrogenase (E1k), dihydrolipoamide succinyl transferase (E2k), and
dihydrolipoamide dehydrogenase (E3). KGDHC catalyzes the oxidative decarboxylation of
α-ketoglutarate (KG) with the concomitant formation of succinyl-CoA and reduction of
NAD+ to NADH (Figure 2). E1k is a ThDP-dependent enzyme that generates a carbanionic
intermediate after the ThDP-dependent decarboxylation of the substrate (Figure 2, reaction
(1). In the course of the overall reaction this intermediate undergoes oxidation by the lipoyl
moiety covalently bound to the second enzyme of the complex, E2k (Figure 2, reaction (2)).
Free lipoate and lipoamide are relatively poor substrates of the α-keto acid dehydrogenases
compared to the protein-bound lipoyl group (69, 70). Nevertheless, free lipoate and
lipoamide may be reductively acylated in the E1k-catalyzed reaction. Also, a number of
small-molecular-weight electron acceptors may participate in the E1k-catalyzed reaction and
can therefore be considered as paracatalytic substrates of E1k. Several aspects of these
paracatalytic reactions deserve attention regarding their potential pathophysiological
significance.
First, the E1k-catalyzed oxidation of α-keto acids is supported by structurally and
chemically different oxidants (electrophiles) (Table 4). Reaction rates at saturating
concentrations of different oxidants may vary by more than an order of magnitude, but
similar saturation with KG is observed with these oxidants (Table 4). Thus, the  values
determined for the paracatalytic reactions are close to the  values measured in
independent experiments under equilibrium conditions (74). This finding shows that the
E1k-generated carbanion is formed rapidly compared to the subsequent oxidation step. That
is, the oxidoreduction step, which is the slowest step of the overall reaction (reaction (2) in
Figure 2), is also slow compared to carbanion formation during paracatalytic side reactions.
Most of the paracatalytic substrates [hexacyanoferrate(III), DCIP, 4-chloro-7-nitro-2,1,3-
benzoxadiazole (NBD–Cl), tetranitromethane] of E1k act as oxidants. After their reduction
by the carbanionic intermediate at the active site, the resulting succinyl residue is transferred
from succinyl-ThDP to water. However, the reaction with 4-chloronitrosobenzene includes
both an oxidoreduction step and an acyl transfer step, producing an N-succinyl hydroxamic
acid (72, 75–77). Analogous reactions are known for other ThDP-dependent enzymes
transforming the “active aldehyde” intermediate of the “natural” substrate in the presence of
4-chloronitrosobenzene to an N-acyl hydroxamic acid (75). The overall reaction catalyzed
by such an enzyme (E) is depicted by:
(22)
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where R = −CH3, −CH2OH, and −CH2CH2CO2H for reactions catalyzed by pyruvate
dehydrogenase (E1p), transketolase, and E1k, respectively. This finding implicates ThDP-
containing enzymes in the metabolic transformation of aromatic nitroso compounds.
A unique feature of E1k in this paracatalytic reaction is that in addition to the N-acyl
hydroxamic acid, E1k also produces significant amounts of other products. These products
include some highly polar unidentified material and N-succinyl 1-hydroxy-4-chloroaniline
(75–77). The N-succinyl 1-hydroxy-4-chloroaniline presumably arises through a Bamberger
rearrangement, where the --OH group migrates from the nitrogen to the aromatic ring (76).
The distribution of the products among the different pathways depends on the reaction
conditions (e.g., salts, pH) (77). The distribution also depends on the enzyme source,
presumably due to subtle differences in active-site structures (72). Table 4 shows that
compared to E. coli E1k, both bovine and porcine E1k exhibit high affinities and high rates
for the paracatalytic reaction with 4-chloronitrosobenzene. This is accompanied by a
significant decrease in N-succinyl hydroxamic acid production in favor of the other products
originating from an electrophilic aromatic intermediate stabilized at the E1k active site.
Second, the E1k-catalyzed paracatalytic reactions occur not only with isolated E1k, which is
not the in vivo form of the enzyme, but also with the E1k in its natural complex-bound state.
Moreover, an increase in the maximal reaction rates with artificial electron acceptors in
intact KGDHC compared to those with isolated E1k is observed, probably due to the overall
stabilization of E1k when bound to the complex (Table 5). Thus, incorporation of E1k into
the native structure of the multienzyme complex does not prevent the paracatalytic reactions.
These findings further support the potential significance of such reactions in vivo.
Third, an irreversible inactivation of E1k occurs in the course of both paracatalytic and
native reactions (78). This process is different from the inactivation resulting from the
nonspecific action of oxidants per se. The catalysis-associated inactivation involves a
reactive catalytic intermediate formed during the oxidoreduction step in the presence of both
the α-keto acid and oxidant substrates of E1k. The fate of this intermediate may differ
depending on the surrounding medium, and in particular, on the substrates that are present.
Table 5 shows that the hexacyanoferrate(III)-dependent oxidation of KG is characterized by
an apparent rate constant for irreversible inactivation (kin)~0.1 min−1. With another α-keto
dicarboxylate substrate of E1k, α-ketoadipate, the kin value is increased up to fivefold, while
dicarboxylates such as glutarate, succinate, and malonate protect E1k from the inactivation
(78).
What are the intermediates and/or side reactions leading to E1k inactivation? As shown in
Fig. 2, the E1k carbanionic intermediate is normally oxidized by a two-electron acceptor, the
E2k-bound lipoyl residue (reaction (2). However, the intermediate can also be efficiently
oxidized by a one-electron acceptor such as hexacyanoferrate(III) (Table 4). A radical of the
carbanionic intermediate of isolated E1k from E. coli was observed by EPR, presumably
resulting from the one-electron oxidation of the intermediate by molecular oxygen (79).
Similar one-electron oxidation reactions take place in pyruvate:ferridoxin oxidoreductases
and in chemical models of key intermediates of thiamine catalysis [reviewed by Bunik and
Sievers (80)]. A reactive intermediate containing an uncoupled electron generated in the
course of a one-electron oxidation could induce a modification of the E1k active site leading
to KGDHC inactivation. This would explain the first-order loss of activity of E1k operating
through a one-electron oxidation in the presence of hexacyanoferrate(III) (Table 4). A strong
oxidant of the E1k-generated carbanion is the stabilized thiyl radical of the complex-bound
lipoyl residue. Experiments on the substrate-dependent reduction of the α-keto acid
dehydrogenase complexes under anaerobic conditions showed that there is transient
formation of complex-bound thiyl radicals of lipoyl residues, which arises from the
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semiquinone species of the E3-bound FAD (80). In the course of the anaerobic reduction of
KGDHC, a carbon-centered radical and a complex-bound thiyl radical were trapped with
5,5′-dimethyl-1-pyrroline-N-oxide (DMPO) and α-phenyl-tert-butylnitrone, respectively.
Production of these radicals coincided with E1k inactivation. These findings support the
mechanism of E1k inactivation during catalysis.
When terminal two-electron oxidation is perturbed or totally blocked (e.g., at limiting or no
NAD+), thiyl radicals of the complex-bound lipoyl moieties may be formed. As shown by
Bunik and Sievers (80), these radicals react with the E1k-generated carbanion through one-
electron oxidation (reaction (23), with the resulting carbon-centered radical species
inactivating E1k according to the following reactions:
(23)
(24)
Further evidence for this mechanism of the E1k inactivation is provided by protection from
the inactivation by a known thiyl radical scavenger thioredoxin (81–83). Thioredoxin
prevents the substrate-induced inactivation by catalyzing dismutation of the complex-bound
thiyl radicals, which arise upon the KGDHC reduction with KG and CoA (Figure 3).
Remarkably, the formation of the thiyl radicals is transient under anaerobic conditions, but
becomes permanent in the presence of O2 because O2 stimulates formation of the
semiquinone species of the complex-bound FADH2 through its one-electron oxidation (80,
82). That is, at saturating concentrations of KG and CoA, the E2k-bound dihydrolipoyl
residues and E3-bound FAD of KGDHC are reduced (reactions (1) to (4) in Figure 2). At
low or zero concentrations of NAD+, O2 competitively oxidizes E3, with the concomitant
formation of O2•− and semiquinone form of the E3-bound FAD. The semiquinone is in
redox equilibrium with the catalytic thiol groups of KGDHC. This redox equilibrium gives
rise to the permanent O2-dependent generation of the complex-bound thiyl radicals of the
lipoyl residues. As a result, the E1k component is inactivated according to reactions (23) and
(24) under both aerobic and anaerobic conditions. However, generation of the inactivating
thiyl radicals under anaerobic conditions occurs by different mechanisms (incomplete
reduction versus an oxidase reaction) and kinetics (transient versus permanent). The
oxidative decarboxylation of KG may thus proceed under low concentrations of NAD+ only
when thioredoxin protects E1k by dismutating the complex-bound thiyl radicals (Figure 3).
Under these conditions, however, the electron flow to O2 is not blocked by E1k inactivation,
leading to accumulation of the superoxide anion radical and the product of its dismutation,
H2O2 (80). Studies with isolated mitochondria (84, 85) and cultivated neurons (86) indicated
the significance of KGDHC for the production of ROS in vivo. Thus, accumulation of ROS
produced by KGDHC and interaction of these ROS with cellular metabolites may
complicate the transformation pathways of the E1k reactive intermediates in vivo.
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It is possible that there are several mechanisms for the paracatalytic inactivation of E1k,
arising under conditions that stabilize different reactive intermediates. Some of these
inactivation mechanisms may be due to the oxygenase side reaction of a catalysis-generated
intermediate, which results in peracid formation. Such an oxygenase reaction at the E1k
active site is supported by the observation that under aerobic conditions, TNB formed upon
thiol modification of E1k by 5,5′-dithiobis(2-nitrobenzoic acid) is consumed in the presence
of KG (87). As pointed out above, TNB consumption may be indicative of peracid
formation resulting from the oxidase/oxygenase reaction of carbanions generated by ThDP-
dependent enzymes (25). A peracid intermediate analogous to that observed in the PDC- and
ALS II–catalyzed oxygenase reactions may well be involved, therefore, in the E1k-catalyzed
process, explaining why paracatalytic inactivation occurs not only in the reaction with the
one-electron acceptor hexacyanoferrate(III), but also with the two-electron acceptor DCIP,
and during the course of the native reaction with the lipoyl-bound moiety at saturating
NAD+. Moreover, an O2-dependent reaction on E1k would explain the rather strong α-keto
acid–dependent inactivation observed with some preparations of E1k (88). This inactivation
varies with the α-keto acid and E1k preparation. These variations may be due to differences
in the stability of reactive intermediates and to structural differences among the isolated E1k
preparations, resulting, for example, from binding of regulatory metal ions to the enzyme
and/or posttranslational modifications. As shown above with other enzymes, such factors
greatly affect the paracatalytic oxidase/oxygenase reactions.
Recently, the isolated E1k component of the KGDHC from E. coli was shown to catalyze an
O2-dependent reaction with KG, the product of which could be detected by the Amplex
Red–peroxidase assay (79). Because formation of resorufin in the Amplex Red assay is
known to be catalyzed by peroxidase in the presence of H2O2, the authors concluded that
H2O2 is the product of the E1k-catalyzed reaction. However, although the Amplex Red–
peroxidase kit is used to assay H2O2-generating enzymes, it cannot be employed as an
analytical tool to prove H2O2 production. In particular, N–C bond scission, which in
Amplex Red leads to resorufin, is known to be catalyzed by peroxidase in the presence not
only of H2O2 but also of peracids (89, 90). Moreover, peracids may generate hydrogen
peroxide hydrolytically (90). Taken together, formation of resorufin, interpreted by Frank et
al. (79) as H2O2 generation by E1k, is also consistent with an E1k-dependent oxygenase
reaction, resulting in peracid formation. EPR detection of the carbanion/enamine–ThDP
radical intermediate in the presence of KG and oxygen (79) led Frank et al. to assume that
the peroxide production occurs through two successive 1e− oxidations of the carbanion/
enamine–ThDP intermediate by two molecules of O2, with the resulting superoxide anion
radical dismutated to the peroxide. However, the radical intermediate detected could arise
from secondary reactions in the presence of peracid or its decomposition product H2O2, or
in a side reaction concomitant with the peracid formation. In addition, the suggested ping-
pong mechanism, in which the ThDP radical intermediate is stable enough to let one
superoxide anion radical leave the E1k active site, and the other oxygen molecule arrive to
accept the second electron, seems much less probable than the reaction sequence proposed
for other ThDP-dependent enzymes in which the carbanionic intermediate reacts with O2,
resulting in peracid formation (25). Remarkably, the resorufin accumulation curves at 1 mM
KG do not show any significant inactivation of the enzyme in the course of this reaction
(79). This is in accord with our study of pig heart KGDHC, in which inactivation in the
presence of KG alone occurred at a rate one order of magnitude lower (k=0.01 min−1) than
under conditions in which the thiyl radical of the complex-bound lipoate was efficiently
generated (k=0.1 min−1) (80). Thus, both the isolated E1k and complex-bound E1k generate
reactive species by oxidizing α-ketoglutarate with O2 (79, 80) without significant
inactivation. The isolated E1p component also generates reactive species by oxidizing
pyruvate with O2 (79). However, under normal physiological conditions (i.e., when the
components are integrated within the multienzyme complexes and the substrates of other
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component enzymes are present as well), side reactions may be blocked rapidly by self-
inactivation (80–82), which is subject to metabolic and redox regulation by substrate
structural analogs (78) and by thioredoxin and/or NADH/NAD+ (81, 82). These data
indicate that natural systems may use paracatalytic enzyme inactivation for limiting side
reactions in vivo. Moreover, for enzymes that produce highly reactive compounds, self-
inactivation in the course of catalysis was shown to be a feasible means of preventing
cellular accumulation of such reactive compounds (91, 92). KGDHC may be classified as
one such enzyme, as it produces ROS, and in vivo ROSs are known to be signal transducers
that become toxic at excessively high levels.
VIII. Potential Role of Paracatalytic Side Reactions in Diseases
A. BACKGROUND
During the course of evolution, nature has made numerous efforts to prevent O2 and other
electrophiles from reacting at the active sites of enzymes that generate carbanionic and/or
radical intermediates. For some enzyme reactions that do not benefit from radical chemistry,
carbanionic intermediates may not require sequestration from molecular O2, but may still
need to be protected from other possible reactants. Those enzymes that do support reactions
with substantial radical character must somehow prevent reaction with molecular O2 and
other radical species that may be present. With the luxury of hindsight, we now know that
enzymes are only as “perfect” as required by natural selection (13). In other words,
excluding O2 may or may not be desirable, but will be decided upon by selection pressure.
Tipping the balance from an inefficient to an efficient oxygenase/oxidase in an enzyme that
catalyzes the formation of a carbanionic intermediate may only require surprisingly minor
alteration in an enzyme's architecture. There are a number of examples when post-
translational modification of amino acid residues of proteins, which typically arise from the
oxygenation of aromatic residues, covalent cross-linking of amino acid residues, or
cyclization or cleavage of internal amino acid residues, may give rise to altered or even new
catalytic functions (93). Thus, as noted above, native pig kidney DDC does not oxidatively
decarboxylate a significant fraction of L-dopa, although it can oxidize dopamine at a
relatively low rate (51, 53). A Y332F mutation results in an enzyme that retains the ability to
catalyze the oxidation of dopamine at a relatively low rate. However, this mutated enzyme
catalyzes a very active oxidative decarboxylation of L-dopa. The Vmax of this reaction is at
least as great as, and possibly greater than, that of the nonoxidative decarboxylation of L-
dopa catalyzed by the native enzyme (50, 53). The affinity of the mutated enzyme for L-dopa
is, however, somewhat lower than that exhibited by the native enzyme (50). These findings
may have important ramifications. It is conceivable, for example, that mutation or chemical
modification could give rise to a modified form of DDC with substantial oxidase/oxygenase
activity. Such modifications of DDC could convert an enzyme that catalyzes a purely
nonoxidative dopa decarboxylation reaction to an enzyme that catalyzes an exclusive or
partial oxidative decarboxylation of L-dopa to an aromatic aldehyde (i.e., 3,4-
dihydroxyphenylacetaldehyde; dopal). Aromatic aldehydes are generated from the action of
DDC on dopamine and serotonin (47), which can then inactivate the enzyme. A damaged or
mutant DDC may generate a greater amount of reactive aromatic aldehyde than native DDC,
resulting in pathology. It is interesting to note that dopal is far more toxic to the substantia
nigra than is dopamine (94). It has been suggested that dopal is a major neurotoxin
contributing to the death of neurons in the substantia nigra (94). Although dopal is generally
regarded as arising via the action of monoamine oxidases on dopamine, it is conceivable that
this reactive aldehyde may also arise as a new activity of a damaged DDC to catalyze
oxidative decarboxylation of L-dopa or to increased ability of the enzyme to oxidize
dopamine.
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In this regard, as noted above, recent findings suggest that defects in DCC, although rare,
occur in human populations (55). As summarized by Allen et al. (55), children with DCC
deficiency present early in life with axial hypotonia, hypokinesia, choreoathetosis,
developmental delay and episodes of dystonia, limb hypertonia, and oculogyric crises.
Autonomic symptoms are common, including nasal congestion, temperature instability, and
excessive sweating. Presumably, the symptoms are related to low levels of dopamine and
serotonin (and products derived therefrom). However, the possibility should also be
considered that a mutated enzyme can convert dopa to neurotoxic dopal.
As noted above, petunia PAAS has strong sequence homology to aromatic amino acid
decarboxylases (57). Based on this finding and the finding that only a relatively simple
mutation can convert DDC from a nonoxidative decarboxylase to an oxidative
decarboxylase (50), it is reasonable to assume that nature readily exploited mutations in the
basic structure of L-aromatic amino acid decarboxylases to maximize interaction of
carbanionic intermediates with O2 in the petunia PAAS. On the other hand, other PLP-
dependent decarboxylases, where oxidative decarboxylation of the L-amino acid to an
aldehyde is not quantitatively an important metabolic process, have evolved to minimize the
interaction of carbanionic intermediates with molecular O2. The fact that the reaction with
O2 has not been eliminated altogether suggests that due to the topology of the active site,
some oxidation with O2 is unavoidable if nonoxidative decarboxylation is to proceed at a
reasonable rate. However, it is also possible that nature may use these side reactions with O2
to regulate decarboxylase activity or to balance normal physiological function at various
oxygen tensions. For example, inhibition of the human vesicle-associated GAD (GAD65)
and porcine CSAD I/II (enzymes that catalyze an important step in the taurine biosynthesis
pathway) by molecular O2 may be involved in maintaining the balance between excitatory
and inhibitory signaling during changes in atmospheric pressure. Failure to maintain balance
due to excessive inhibition of GAD65 is thought to contribute to the genesis of oxygen-
induced seizures (e.g., seizures that result from extended underwater dives on compressed
air) (41, 46).
Certain enzymes can catalyze new or increased paracatalytic reactions if the natural metal
ion cofactor is replaced by an inappropriate metal ion. For example, as noted above,
replacement of active site Mg2+ with Co2+ in Rhodospirillum rubrum Rubisco converts the
enzyme from a partial oxygenase into an exclusive oxygenase (38). We suggest that
enhancement of oxygenase/oxidase activity in some carbanion-forming enzymes by
alterations of the topology of the active site and/or exposure to an inappropriate metal may
also occur in mammalian enzymes and contribute to metabolic stress in various diseases. For
example, zinc homeostasis is thought to be perturbed in Alzheimer disease (AD) brain (95).
Even sub-μM amounts of Zn2+ can promote, by as much as fivefold, the NADH oxidation
by O2 catalyzed by the E3 component of KGDHC (96).
B. POSSIBLE ROLE OF ThDP IN THE PARACATALYTIC BIOACTIVATION OF N-NITROSO
COMPOUNDS AND RELEVANCE TO CANCER INDUCTION
As discussed above, some nitroso compounds are converted to N-acyl hydroxamic acids in
the presence of “active aldehyde” [reaction (22)] at the active sites of E1p, transketolase, and
E1k (97). Due to its ability to accommodate bulky substrates at the active site, the BCDHC
can participate in the biotransformation of N-nitroso aromatic compounds producing N-
hydroxyarylamines (98). In a similar fashion, a transketolase-mediated reaction of nitroso
aromatic compounds with fructose-6-phosphate can produce N-hydroxy-N-arylglycolamides
(98). The formation of N-hydroxy-N-acetamide and N-hydroxyarylamines is facilitated by
PDHC and BCDHC, respectively (98, 99). The formation of these derivatives is enhanced
by cofactors (Mg2+ and ThDP) and inhibited by thiamine thiazolone pyrophosphate, a
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specific inhibitor of ThDP-dependent enzymes (98). These reactions may be very important
in the bioactivation (toxification) of N-nitroso compounds.
Humans are exposed to N-nitroso compounds by exogenous routes (from processed meats in
particular) and by endogenous routes. A variety of N-nitroso compounds are derived
primarily from reaction of amides, substituted ureas, or aromatic amines within the stomach
and intestines as a result of oral and gastric bacterial degradation of nitrates to nitrites, both
common food additives used in the processing of ham, sausages, and other meat products to
prevent the colonization of Clostridia bacteria. Red meat may contribute to the formation of
colorectal cancers by exposure to N-nitroso compounds, and endogenous exposure to N-
nitroso compounds is dose-dependently related to the amount of red meat in the diet (100).
The polycyclic aromatic hydrocarbons (PAHs) contained in smoked and charcoal-broiled
foods can be converted to N-substituted aromatic compounds and direct-acting mutagens by
treatment with nitrite in acidic media. Thus, simultaneous consumption of charcoal-broiled
and smoked foods with nitrite-containing food may contribute to esophageal, stomach, and
colorectal tumors (101). Similarly, intragastric nitrosation of 4-chloroindole and of 4-
chloro-6-methoxyindole in fava beans (Vicia faba) with nitrite yields a direct-acting
mutagen, 4-chloro-2-hydroxy-N1-nitroso-indolin-3-one oxime, a stable α-hydroxy N-
nitrosylated compound (102). Other naturally occurring N-substituted aromatic compounds
have been identified in a widely consumed tea from India (Kashmir), which are responsible
for a high incidence of esophageal and stomach cancer in that area. Mononitrosocaffeidine
and dinitrosocaffeidine are obtained from in vitro nitrosation of caffeidine, a hydrolysis
product of caffeine present in the Kashmir tea (103). In addition, after nitrosation, naturally
occurring aromatic amines, especially 2-carboline derivatives such as harman, norharman,
harmaline, harmalol, harmine, and harmol, become more mutagenic to Salmonella
typhimurium (104). Under gastric conditions, piperidine, detected in popular white and
black pepper powders, reacts readily with nitrite to form carcinogenic N-nitroso-piperidine
(105).
N-Substituted aromatic compounds have been implicated in induction of cancers and DNA
mutations due to metabolic transformation into N-hydroxyarylamines and N-acyl
hydroxamic acids, which can react with DNA after bioactivation into reactive electrophiles.
As noted above, both of these classes of compounds can arise through paracatalytic
reactions of aromatic N-nitroso compounds with aldehydes at the active sites of a number of
ThDP-containing enzymes. The mechanism by which hydroxylamines and N-acyl
hydroxamic acids are bioactivated is beyond the scope of this review, but it is worth
mentioning that the bioactivation of the latter group of compounds appears to involve N-
acyltransferase reactions (106). These reactions show certain degrees of similarity to S-
acyltransferase reactions catalyzed by the ThDP-dependent E1p and E1k (99).
C. CRITICAL INVOLVEMENT OF KGDHC IN NEURODEGENERATIVE DISEASES
Considerable evidence has accumulated during the past two decades that reduction of brain
KGDHC activity is inherent in the pathophysiology of thiamine deficiency and
neurodegenerative diseases, such as AD, Parkinson disease, Huntington disease, Wernicke–
Korsakoff disease, and progressive supranuclear palsy [for a review, see the article by
Gibson et al. (107)]. Whether the neurodegeneration-associated inactivation of KGDHC is
primary or secondary, the loss of activity would strongly aggravate the disease state, due to
the key position of KGDHC at a branch point of the central metabolism of mitochondria,
organelles known to play an important role in cell death. In particular, AD is associated with
loss of neurons with a high KGDHC content and with a specific decrease of KGDHC
activity in cortex and hippocampus (108). Cortex and hippocampus provide trophic support
for cholinergic neurons of the forebrain basal nucleus and produce nerve growth factor
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(NGF), a deficit of which occurs in AD brain (109). Impairment of energy metabolism due
to diminished KGDHC activity will disturb the levels of trophic factors.
Although the mechanisms by which KGDHC is inactivated in diseased brain are not clear, it
is thought that metabolic imbalance and oxidative stress under disease conditions may
contribute to the reduced KGDHC activity. The findings summarized in the present review
may suggest potential mechanisms. For example, KGDHC activity is diminished in
Wernicke–Korsakoff syndrome, a neuropsychiatric disorder that is induced in humans by
thiamine deficiency as a result of chronic alcoholism (110) and in some cases by
hyperemesis gravidarum. Curiously, however, the content of the thiamine-dependent E1k is
increased by as much as threefold in rats exposed to ethanol (111). Taken together, these
data suggest that increased E1k expression may be a compensatory response to E1k-
dependent KGDHC inactivation resulting from alcohol-induced stress. It is well established
that excessive alcohol consumption increases the NADH/NAD+ ratio in liver. This increased
NADH/NAD+ ratio should promote thiyl radical formation by KGDHC, thereby increasing
E1k inactivation according to reactions (23) and (24). The possibility of paracatalytic
inactivation of E1k under pathological conditions is supported by our finding that the
glutamate excitotoxicity toward neurons is significantly alleviated by synthetic analogs of
KG, which protect KGDHC from paracatalytic inactivation (112). Because glutamate
excitotoxicity is known to contribute greatly to hypoxic–ischemic damage to both adult and
developing brain, we tested analogs of KG in vivo as neuroprotective agents, using a model
of prenatal hypoxia. Exposure of pregnant rats to KG analogs was shown to alleviate
hypoxic damage to their offspring (113). It is worth noting that the glutamate neurotoxicity
observed in neurodegenerative diseases is associated with increased ROS production in
overstimulated neurons (114). Using specific inhibitors of cellular E1k (115), we showed
that neuronal KGDHC contributes significantly to the ROS production in response to
glutamate overstimulation (86). The biological significance of the KGDHC-dependent
paracatalytic reactions involving E1k-E3 interaction is supported further by the fact that
KGDHC from brain possesses a specific isoform of E1k and a lower E3 content than that of
the heart complex (116). Structural differences between the two E1k isoforms (117) and the
role of E1k in the E3 binding to the complex (118) suggest that the lower E3 content of brain
KGDHC is determined by the structure of the brain-specific isoform of E1k. The decreased
content of E3 in the brain KGDHC may thus represent an additional means by which the
brain is protected from excessive ROS generation.
On the basis of the observed diversity of the oxidants accepted at the E1k active site (Table
4) and diverse chemistry of the interaction of these oxidants with the E1k active site as
discussed in the present review, we wish to emphasize the possibility that some xenobiotics
and some metabolites not on the main catalytic sequence shown in Figure 2 may be
paracatalytic substrates of E1k in vivo, oxidizing the carbanionic intermediate formed in
reaction (1). These paracatalytic reactions may result in products detrimental to KGDHC
itself and/or to the mitochondrial milieu. For example, E1k paracatalytic substrates might
very well include cellular quinones, which are well known to be highly electrophilic. This
possibility is supported by study of the cellular toxicity of coenzyme Q0. KGDHC interacts
with this quinone in vivo as documented by adduction of coenzyme Q0 to E2k and
protection from this modification by coenzymes Q1 and Q2 upon incubation of cells with the
various quinones (119).
An important factor in the KG plus CoA-dependent generation of ROS by KGDHC is that
the ROS are produced concomitantly with, and in the vicinity of, CO2/HCO3−, which are
known to greatly increase the damaging potential of ROS (120, 121) and peroxynitrite (122).
For example, bicarbonate enhances the radical-dependent oligomerization and nitration of
the neuronal presynaptic protein α-synuclein, which is known to be a component of
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potentially toxic Lewy bodies in neurodegenerative disorders (122). Furthermore, CO2/
HCO3− mediates the Mn2+ -catalyzed decomposition of H2O2, initiating a chain of
biologically hazardous processes (121, 123). The structural and functional interaction of E1k
and E3 within KGDHC is especially important in this regard because (1) the E3-produced
ROS may be coupled to KG oxidative decarboxylation, resulting in CO2 formation, and (2)
some mammalian E1k subunits are known to bind Mn2+ and other metal ions in addition to
the catalytically essential Mg2+ (124, 125). We conclude that changes in the cellular
proteome and metabolome that occur as a result of neurodegenerative diseases may affect
paracatalytic reactions of E1k. Stimulation of such reactions may not only decrease the
energy production by KGDHC but also damage the cellular milieu through generation of
reactive metabolites by KGDHC. Further study of the mechanism of the E1k catalysis and
biologically occurring paracatalytic substrates will lead to a greater understanding of the
complex processes which take place in diseased brain. Such an understanding may suggest
new avenues for safe and effective treatment modalities against devastating
neurodegenerative diseases.
IX. Conclusions
Many enzymes possess the ability to catalyze paracatalytic (including oxygenase/oxidase)
side reactions with carbanionic intermediates. In some cases, this may be the result of an
evolutionary balance between generating a biologically acceptable level of the “natural”
product and a biologically acceptable level of a toxic or “nonproductive” side product.
These side reactions may have additional consequences. For example, they may be used to
regulate O2 levels or enzyme activities. However, under pathological conditions, these side
reactions may contribute to cancer induction and to the dysfunctions of cerebral metabolism
during aging or in neurodegenerative diseases. The possibility exists that products resulting
from enzyme-catalyzed paracatalytic reactions, including oxygenase/oxidase side reactions,
may be elevated in aging and neurodegenerative diseases by (a) provision of an
inappropriate metal, (b) increased availability of reactive electrophile/oxidant (e.g.,
quinones), and/or (c) oxidative stress–induced modification of an enzyme. Inhibition of
PLP-dependent decarboxylases, such as human GAD65, by molecular O2 could be
responsible for acute manifestations of oxygen toxicity, such as O2-induced seizures during
diving. Disruption of glutamate and dopamine levels as a result of dysregulation of GAD
and DDC may also have strong implications for neurodegenerative diseases. Finally,
decreased NADH production by KGDHC, which is a robust finding for several
neurodegenerative diseases, no doubt contributes to the decline in cerebral energy
metabolism in many neurodegenerative diseases. However, paracatalytic activities of
KGDHC may be activated under these conditions and aggravate the disease state due to
other factors as well. The disease-induced modifications of enzymes and cellular milieu (in
particular, perturbed thiol redox status, an increased NADH/NAD+ ratio, and a perturbed
metal ion balance) may increase oxidative stress in AD brain by stimulating production of
O2•− and H2O2. Pharmacological treatments may have side effects through the paracatalytic
generation of hazardous compounds. Together, these factors could lead to a vicious cycle in
which cellular metabolism is compromised.
Acknowledgments
V.I.B. greatly acknowledges support from Russian Foundation of Basic Research (grants 09-04-90473 and
10-04-90007) and long-standing support of her work on the mechanism of the KGDHC catalysis and regulation by
the Alexander von Humboldt Foundation (Bonn, Germany). J.V.S. gratefully acknowledges support by the Office
of Naval Research (N00014-94-1-0457; N00014-00-1-01-02; N00014-03-1-0450) and NIH (RO1GM48568), U.S.-
Israel Binational Science Foundation, and the Gustavus and Louise Pfeiffer Research Foundation. Work cited from
the A.J.L.C. laboratory was supported by NIH grants PO1 AG14930 and RO1 AG19589, and work from the N.D.
BUNIK et al. Page 24













laboratory was supported in part by the U.S.-Israel Binational Agriculture Research and Development funds, grant
US-3437-03.
References
1. Healy MJ, Christen P. Reaction of the carbanionic aldolase-substrate intermediate with
tetranitromethane: identification of the products, hydroxypyruvaldehyde phosphate and D-5-
ketofructose 1,6-diphosphate. J. Am. Chem. Soc. 1972; 94:7911–7916. [PubMed: 5076758]
2. Healy MJ, Christen P. Mechanistic probes for enzymatic reactions: oxidation–reduction indicators
as oxidants of intermediary carbanions (studies with aldolase, aspartate aminotransferase, pyruvate
decarboxylase, and 6-phosphogluconate dehydrogenase). Biochemistry. 1973; 12:35–41. [PubMed:
4566929]
3. Christen P, Anderson TK, Healy MJ. H2O2 oxidizes an aldolase dihydroxyacetone phosphate
intermediate to hydroxymethylglyoxal phosphate. Experientia. 1974; 30:603–605. [PubMed:
4837070]
4. Christen P, Gasser A. Oxidation of the carbanion intermediate of transaldolase by
hexacyanoferrate(III). J. Biol. Chem. 1976; 251:4220–4223. [PubMed: 776982]
5. Christen P, Cogoli-Greuter M, Healy MJ, Lubini D. Specific irreversible inhibition of enzymes
concomitant to the oxidation of carbanionic enzyme– substrate intermediates by
hexacyanoferrate(III). Eur. J. Biochem. 1976; 63:223–231. [PubMed: 770167]
6. Christen P. Paracatalytic enzyme modification by oxidation of enzyme– substrate carbanion
intermediates. Methods Enzymol. 1977; 46:48–54. [PubMed: 561875]
7. Cogoli-Greuter M, Hausner U, Christen P. Irreversible inactivation of pyruvate decarboxylase in the
presence of substrate and an oxidant: an example of paracatalytic enzyme inactivation. Eur. J.
Biochem. 1979; 100:295–300. [PubMed: 385313]
8. Christen P, Gasser A. Production of glycolate by oxidation of the 1,2-dihydroxyethyl-thamin-
diphosphate intermediate of transketolase with hexacyanoferrate (III) or H2O2. Eur. J. Biochem.
1980; 107:73–77. [PubMed: 6995116]
9. Bowes G, Ogren WL. Oxygen inhibition and other properties of soybean ribulose 1,5-diphosphate
carboxylase. J. Biol. Chem. 1972; 247:2171–2176. [PubMed: 5062819]
10. Ryan FJ, Tolbert NE. Ribulose diphosphate carboxylase/oxygenase: III. Isolation and properties. J.
Biol. Chem. 1975; 250:4229–4233. [PubMed: 236314]
11. Chen ZX, Chastain CJ, Al-Abed SR, Chollet R, Spreitzer RJ. Reduced CO2/O2 specificity of
ribulose-bisphosphate carboxylase/oxygenase in a temperature-sensitive chloroplast mutant of
Chlamydomonas. Proc. Natl. Acad. Sci. USA. 1988; 85:4696–4699. [PubMed: 3133659]
12. Yu G-X, Park B-H, Chandramohan P, Geist A, Samatova NF. An evolution-based analysis scheme
to identify CO2/O2 specificity-determining factors for ribulose 1,5-bisphosphate carboxylase/
oxygenase. Protein Eng. Des. Sel. 2005; 18:589–596. [PubMed: 16246824]
13. Schloss, JV.; Hixon, MS. Enol chemistry and enzymology. In: Sinnod, M., editor. Comprehensive
Biological Catalysis, Vol. 2, Reactions of Nucleophilic/Carbanionoid Carbon. Academic Press;
London: 1998. p. 43-114.
14. Ogren WL. Affixing the O to Rubisco: discovering the source of photorespiratory glycolate and its
regulation. Photosynth. Res. 2003; 76:53–63. [PubMed: 16228565]
15. Abell LM, Schloss JV. Oxygenase side reactions of acetolactate synthase and other carbanion-
forming enzymes. Biochemistry. 1991; 30:7883–7887. [PubMed: 1868063]
16. Hixon M, Sinerius G, Schneider A, Walter C, Fessner W-D, Schloss JV. Quo vadis
photorespiration: a tale of two aldolases. FEBS Lett. 1996; 392:281–284. [PubMed: 8774862]
17. Fessner W-D, Schneider A, Held H, Sinerius G, Walter C, Hixon M, Schloss JV. The mechanism
of class II, metal-dependent aldolases. Angew. Chem. Int. Ed. Engl. 1996; 35:2219–2221.
18. Duggleby RG, McCourt JA, Guddat LW. Structure and mechanism of inhibition of plant
acetohydroxyacid synthase. Plant Physiol. Biochem. 2008; 46:309–324. [PubMed: 18234503]
19. Hixon, MS. Ph.D. dissertation. University of Kansas; 1997. Oxygen consuming side reactions of
carbanion forming enzymes: the accidental oxygenases.
BUNIK et al. Page 25













20. Tse JM-T, Schloss JV. The oxygenase reaction of acetolactate synthase. Biochemistry. 1993;
32:10398–10403. [PubMed: 8399183]
21. Lubini DGE, Christen P. Paracatalytic modification of aldolase: a side reaction of the catalytic
cycle resulting in irreversible blocking of two active-site lysyl residues. Proc. Natl. Acad. Sci.
USA. 1979; 76:2527–2531. [PubMed: 288042]
22. Schloss, JV. Interaction of the herbicide sulfometuron methyl with acetolactate synthase: a slow-
binding inhibitor. In: Bray, RC.; Engel, PC.; Mayhew, SG., editors. Flavins and Flavoproteins.
Walter de Gruyter; New York: 1984. p. 737-740.
23. Schloss, JV.; Ciskanik, L.; Pai, EF.; Thorpe, C. Acetolactate synthase: a deviant flavoprotein. In:
Curti, B.; Ronchi, S.; Zanetti, G., editors. Flavins and Flavoproteins. Walter de Gruyter; New
York: 1991. p. 907-914.
24. Tittmann K, Schröder K, Golbik R, McCourt J, Kaplun A, Duggleby RG, Barak Z, Chipman DM,
Hübner G. Electron transfer in acetohydroxy acid synthase as a side reaction of catalysis.
Implications for the reactivity and partitioning of the carbanion/enamine form of (α-
hydroxyethyl)thiamin diphosphate in a “nonredox” flavoenzyme. Biochemistry. 2004; 43:8652–
8661. [PubMed: 15236573]
25. Schloss, JV.; Hixon, MS.; Chu, F.; Chang, S.; Duggleby, RG. Products formed in the oxygen-
consuming reactions of acetolactate synthase and pyruvate decarboxylase. In: Bisswanger, H.;
Schellenberger, A., editors. Biochemistry and Physiology of Thiamin Diphosphate Enzymes.
Intemann, Prien; Germany: 1996. p. 580-585.
26. Grabau C, Cronan JE Jr. Nucleotide sequence and deduced amino acid sequence of Escherichia
coli pyruvate oxidase, a lipid-activated flavoprotein. Nucleic Acids Res. 1986; 14:5449–5460.
[PubMed: 3016647]
27. Schloss JV, Ciskanik LM, Van Dyk DE. Origin of the herbicide binding site of acetolactate
synthase. Nature. 1988; 331:360–362.
28. Schloss, JV. 1984. (E.I. Du Pont de Nemours & Co.), unpublished work
29. Schloss, JV. Recent advances in understanding the mechanism and inhibition of acetolactate
synthase. In: Stetter, J., editor. Chemistry of Plant Protection. Vol. Vol. 10. Springer-Verlag;
Berlin: 1994. p. 3-14.
30. Ibdah M, Bar-Ilan A, Livnah O, Schloss JV, Barak Z, Chipman DM. Homology modeling of the
structure of bacterial acetohydroxy acid synthase and examination of the active site by site-
directed mutagenesis. Biochemistry. 1996; 35:16282–16291. [PubMed: 8973202]
31. McCourt JA, Pang SS, Guddat LW, Duggleby RG. Elucidating the specificity of binding of
sulfonylurea herbicides to acetohydroxyacid synthase. Biochemistry. 2005; 44:2330–2338.
[PubMed: 15709745]
32. McCourt JA, Pang SS, King-Scott J, Guddat LW, Duggleby RG. Herbicide-binding sites revealed
in the structure of plant acetohydroxyacid synthase. Proc. Natl. Acad. Sci. USA. 2006; 103:569–
573. [PubMed: 16407096]
33. Chipman D, Barak Z, Schloss JV. Biosynthesis of 2-aceto-2-hydroxy acids: acetolactate synthases
and acetohydroxyacid synthases. Biochim. Biophys. Acta. 1998; 1385:401–419. [PubMed:
9655946]
34. Grueninger D, Schulz GE. Antenna domain mobility and enzymatic reaction of l-rhamnulose-1-
phosphate aldolase. Biochemistry. 2008; 47:607–614. [PubMed: 18085797]
35. Kroemer M, Schulz GE. The structure of l-rhamnulose-1-phosphate aldolase (class II) solved by
low-resolution SIR phasing and 20-fold NCS averaging. Acta Crystallogr. D. 2002; 58:824–832.
[PubMed: 11976494]
36. Kroemer M, Merkel I, Schulz GE. Structure and catalytic mechanism of l-rhamnulose-1-phosphate
aldolase. Biochemistry. 2003; 42:10560–10568. [PubMed: 12962479]
37. Hong J, Sun S, Derrick T, Larive C, Schowen KB, Schowen RL. Transition-state theoretical
interpretation of the catalytic power of pyruvate decarboxylases: the roles of static and dynamical
considerations. Biochim. Biophys. Acta. 1998; 1385:187–200. [PubMed: 9655907]
38. Christeller JT. The effects of bivalent cations on ribulose bisphosphate carboxylase/oxygenase.
Biochem. J. 1981; 193:839–844. [PubMed: 6796054]
BUNIK et al. Page 26













39. Bertoldi M, Carbone V, Borri Voltattorni C. Ornithine and glutamate decarboxylases catalyse an
oxidative deamination of their α-methyl substrates. Biochem. J. 1999; 342:509–512. [PubMed:
10477260]
40. Chang, S. Ph.D. dissertation. University of Kansas; 2005. On the oxygenase activity of bacterial
glutamate decarboxylase: an examination of the kinetic mechanism.
41. Davis K, Foos T, Wu J-Y, Schloss JV. Oxygen-induced seizures and inhibition of human
glutamate decarboxylase and porcine cysteine sulfinic acid decarboxylase by oxygen and nitric
oxide. J. Biomed. Sci. 2001; 8:359–364. [PubMed: 11455199]
42. Davis, K.; Schloss, JV. Unpublished work. University of Kansas; Lawrence, KS: 1999.
43. Schloss JV. Significance of slow binding enzyme inhibition and its relationship to reaction-
intermediate analogues. Acc. Chem. Res. 1988; 21:348–353.
44. Choi SY, Churchich JE. Glutamate decarboxylase side reactions catalyzed by the enzyme. Eur. J.
Biochem. 1986; 160:515–520. [PubMed: 3536509]
45. Porter TG, Martin DL. Rapid inactivation of brain glutamate decarboxylase by aspartate. J.
Neurochem. 1987; 48:67–72. [PubMed: 2878977]
46. Li Q, Guo M, Xu X, Xiao X, Xu W, Sun X, Tao H, Li R. Rapid decrease of GAD 67 content
before the convulsion induced by hyperbaric oxygen exposure. Neurochem. Res. 2008; 33:185–
193. [PubMed: 17712632]
47. Bertoldi M, Moore PS, Maras B, Dominici P, Borri Voltattorni CB. Mechanism-based inactivation
of dopa decarboxylase by serotonin. J. Biol. Chem. 1996; 271:23954–23959. [PubMed: 8798628]
48. Bertoldi M, Dominici P, Moore PS, Maras B, Borri Voltattorni CB. Reaction of dopa
decarboxylase with α-methyldopa leads to an oxidative deamination producing 3,4-
dihydroxyphenylacetone, an active site directed affinity label. Biochemistry. 1998; 37:6552–6561.
[PubMed: 9572873]
49. Bertoldi M, Frigeri P, Paci M, Borri Voltattorni CB. Reaction specificity of native and nicked 3,4-
dihydroxyphenylalanine decarboxylase. J. Biol. Chem. 1999; 274:5514–5521. [PubMed:
10026165]
50. Bertoldi M, Gonsalvi M, Contestabile R, Borri Voltattorni CB. Mutation of tyrosine 332 to
phenylalanine converts dopa decarboxylase into a decarboxylation-dependent oxidative
deaminase. J. Biol. Chem. 2002; 277:36357–36362. [PubMed: 12118007]
51. Bertoldi M, Borri Voltattorni C. Reaction and substrate specificity of recombinant pig kidney dopa
decarboxylase under aerobic and anaerobic conditions. Biochim. Biophys. Acta. 2003; 1647:42–
47. [PubMed: 12686106]
52. Bertoldi M, Cellini B, Maras B, Borri Voltattorni C. A quinonoid is an intermediate of oxidative
deamination reaction catalyzed by dopa decarboxylase. FEBS Lett. 2005; 579:5175–5180.
[PubMed: 16150447]
53. Bertoldi M, Cellini B, Montioli R, Borri Voltattorni C. Insights into the mechanism of oxidative
deamination catalyzed by dopa decarboxylase. Biochemistry. 2008; 47:7187–7195. [PubMed:
18547057]
54. O'Leary MH, Baughn RL. Decarboxylation-dependent transamination catalyzed by mammalian
3,4-dihydroxyphenylalanine decarboxylase. J. Biol. Chem. 1977; 252:7168–7173. [PubMed:
561784]
55. Allen GF, Land JM, Heales SJ. A new perspective on the treatment of aromatic l-amino acid
decarboxylase deficiency. Mol. Genet. Metab. 2009; 97:6–14. [PubMed: 19231266]
56. Sakai K, Miyasako Y, Nagatomo H, Watanabe H, Wakayama M, Moriguchi M. l-Ornithine
decarboxylase from Hafnia alvei has a novel l-ornithine oxidase activity. J. Biochem. 1997;
122:961–968. [PubMed: 9443811]
57. Kaminaga Y, Schnepp J, Peel G, Kish CM, Ben-Nissan G, Weiss D, Orlova I, Lavie O, Rhodes D,
Wood K, et al. Plant phenylacetaldehyde synthase is a bifunctional homotetrameric enzyme that
catalyzes phenylalanine decarboxylation and oxidation. J. Biol. Chem. 2006; 281:23357–23399.
[PubMed: 16766535]
58. Kato Y, Tsuda Y, Asano Y. Purification and partial characterization of N-hydroxy-l-phenylalanine
decarboxylase/oxidase from Bacillus sp. strain Ox-B1, an enzyme involved in the “aldoximine–
nitrile” pathway. Biochim. Biophys. Acta. 2007; 1774:856–965. [PubMed: 17544345]
BUNIK et al. Page 27













59. Tapia O, Andrés J. Towards an explanation of carboxylation/oxygenation bifunctionality in
Rubisco: transition structure for the carboxylation reaction of 2,3,4-pentanetriol. J. Mol. Eng.
1992; 2:37–41.
60. Andrés J, Safont VS, Tapia O. Straining the double bond in 1,2-dihydroxyethylene: a simple
theoretical model for the enediol moiety in Rubisco's substrate and analogs. Chem. Phys. Lett.
1992; 198:515–520.
61. Andrés J, Safont VS, Queralt J, Tapia O. A theoretical study of the singlet-triplet energy gap
dependence upon rotation and pyramidalization for 1,2-dihydroxyethylene: a simple model to
study the enediol moiety in Rubisco's substrate. J. Phys. Chem. 1993; 97:7888–7893.
62. Dolphin, D.; Poulson, R.; Avramović, O., editors. Vitamin B6 Pyridoxal Phosphate. Wiley; New
York: 1986.
63. Amadasi A, Bertoldi M, Contestabile R, Bettati S, Cellini B, di Salvo ML, Borri Voltattorni C,
Bossa F, Mozzarelli A. Pyridoxal 5′-phosphate enzymes as targets for therapeutic agents. Curr.
Med. Chem. 2007; 14:1291–1324. [PubMed: 17504214]
64. Agnihotri G, Liu HW. PLP and PMP radicals: a new paradigm in coenzyme B6 chemistry. Bioorg.
Chem. 2001; 29:234–257. [PubMed: 16256695]
65. Lepore BW, Ruzicka FJ, Frey PA, Ringe DT. The x-ray crystal structure of lysine-2,3-
aminomutase from Clostridium subterminale. Proc. Natl. Acad. Sci. USA. 2005; 102:13819–
13824. [PubMed: 16166264]
66. Berkovitch F, Behshad E, Tang KH, Enns EA, Frey PA, Drennan CL. A locking mechanism
preventing radical damage in the absence of substrate, as revealed by the x-ray structure of lysine
5,6-aminomutase. Proc. Natl. Acad. Sci. USA. 2004; 101:15870–15875. [PubMed: 15514022]
67. Agnihotri G, Liu YN, Paschal BM, Liu HW. Identification of an unusual [2Fe–2S]-binding motif
in the CDP-6-deoxy-D-glycero-l-threo-4-hexu-lose-3-dehydrase from Yersinia
pseudotuberculosis: implication for C-3 deoxygenation in the biosynthesis of 3,6-dideoxyhexoses.
Biochemistry. 2004; 43:14265–14274. [PubMed: 15518577]
68. Süumegi B, Alkonyi I. Paracatalytic inactivation of pig heart pyruvate dehydrogenase complex.
Arch. Biochem. Biophys. 1983; 223:417–424. [PubMed: 6859868]
69. Frey PA, Flournoy DS, Gruys K, Yang Y-S. Intermediates in reductive transacetylation catalyzed
by pyruvate dehydrogenase complex. Ann. NY Acad. Sci. 1989; 573:21–35. [PubMed: 2699398]
70. Graham LD, Packman LC, Perham RN. Kinetics and specificity of reductive acylation of lipoyl
domains from 2-oxo acid dehydrogenase multienzyme complexes. Biochemistry. 1989; 28:1574–
1581. [PubMed: 2655695]
71. Bunik, VI. Unpublished work. Lomonosov Moscow State University; Moscow, Russia: 1987.
72. Doerge DR, Corbett MD. The action of α-ketoglutarate dehydrogenase on 4-chloronitrosobenzene:
evidence for species-dependent differences in active site properties. Comp. Biochem. Physiol.
1985; 80C:161–165.
73. Carlberg I, Mannervik B. Interaction of 2,4,6-trinitrobenzenesulfonate and 4-chloro-7-
nitrobenzo-2-oxa-1,3-diazole with the active sites of glutathione reductase and lipoamide
dehydrogenase. Acta Chem. Scand. B. 1980; 34:144–146.
74. Bunik, FVI.; Gomazkova, VS. Study of 2-oxoglutarate dehydrogenase by the method of chemical
modification of amino acid residues. In: Kurganov, BI.; Nagradova, NK.; Lavrik, OI., editors.
Chemical Modification of Enzymes. Nova Science Publishers; New York: 1996. p. 479-521.
75. Corbett MD, Chipko BR. Comparative aspects of hydroxamic acid production by thiamine-
dependent enzymes. Bioorg. Chem. 1980; 9:273–287.
76. Corbett MD, Corbett BR, Doerge DR. Hydroxamic production and active-site induced Bamberger
rearrangement from the action of α-ketoglutarate dehydrogenase on 4-chloronitrosobenzene. J.
Chem. Soc. Perkin Trans. I. 1982:345–350.
77. Corbett MD, Doerge DR, Corbett BR. Hydroxamic acid production by α-ketoglutarate
dehydrogenase: 2. Evidence for an electrophilic reaction intermediate at the enzyme active site. J.
Chem. Soc. Perkin Trans. I. 1983:765–769.
78. Bunik VI, Pavlova OG. Inactivation of α-ketoglutarate dehydrogenase during its enzymatic
reaction. Biochemistry (Moscow). 1997; 62:973–982. [PubMed: 9527444]
BUNIK et al. Page 28













79. Frank RAW, Kay CWM, Hirst J, Luisis BF. Off-pathway oxygen-dependent thiamine radical in
the Krebs cycle. J. Am. Chem. Soc. 2008; 130:1662–1668. [PubMed: 18183975]
80. Bunik VI, Sievers C. Inactivation of the 2-oxo acid dehydrogenase complexes upon generation of
intrinsic radical species. Eur. J. Biochem. 2002; 269:5004–5015. [PubMed: 12383259]
81. Bunik V. Increased catalytic performance of the 2-oxoacid dehydrogenase complexes in the
presence of thioredoxin, a thiol-disulfide oxidoreductase. J. Mol. Catal. B. 2000; 8:165–174.
82. Bunik VI. 2-Oxo acid dehydrogenase complexes in redox regulation. Eur. J. Biochem. 2003;
270:1036–1042. [PubMed: 12631263]
83. Bunik V, Raddatz G, Lemaire S, Meyer Y, Jacquot J-P, Bisswanger H. Interaction of thioredoxins
with target proteins: role of particular structural elements and electrostatic properties of
thioredoxins in their interplay with 2-oxoacid dehydrogenase complexes. Protein Sci. 1999; 8:65–
74. [PubMed: 10210184]
84. Starkov AA, Fiskum G, Chinopoulos C, Lorenzo BJ, Browne SE, Patel MS, Beal MF.
Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species. J.
Neurosci. 2004; 24:7779–7788. [PubMed: 15356189]
85. Tretter L, Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by α-
ketoglutarate dehydrogenase. J. Neurosci. 2004; 24:7771–7778. [PubMed: 15356188]
86. Z€undorf G, Kahlert S, Bunik VI, Reiser G. α-Ketoglutarate dehydrogenase contributes to
production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ.
Neuroscience. 2009; 158:610–616. [PubMed: 18996448]
87. Bunik, VI. Unpublished work. Lomonosov Moscow State University; Moscow, Russia: 1989.
88. Pavlova, OG. Ph.D. dissertation. Lomonosov Moscow State University; Moscow, Russia: 1996.
Interaction of α-ketoglutarate dehydrogenase from pigeon breast muscle with the α-keto substrate
and its structural analogs.
89. Kedderis GL, Hollenberg PF. Characterization of the N-demethylation reactions catalyzed by
horseradish peroxidase. J. Biol. Chem. 1983; 258:8129–8138. [PubMed: 6863282]
90. Schonbaum GR, Lo S. Interaction of peroxidases with aromatic peracids and alkyl peroxides.
Product analysis. J. Biol. Chem. 1972; 247:3353–3360. [PubMed: 5063682]
91. Varfolomeev SD. Enzyme inactivation in the reaction process. Regulatory role [Russian].
Biokhimiia. 1984; 49:723–735. [PubMed: 6743701]
92. Sud'ina GF, Kobel'kov GM, Varfolomeev SD. The macrokinetic behavior of an enzymatic system
with an enzyme inactivated in the reaction. Biotechnol. Bioeng. 1987; 29:625–632. [PubMed:
18576493]
93. Davidson VL. Protein-derived cofactors. Expanding the scope of post-translational modifications.
Biochemistry. 2007; 46:5283–5292. [PubMed: 17439161]
94. Burke WJ, Li SW, Williams EA, Nonneman R, Zahm DS. 3,4-Dihydroxyphenylacetaldehyde is the
toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis. Brain Res.
2003; 989:205–213. [PubMed: 14556942]
95. Finefrock AE, Bush AI, Doraiswamy PM. Current status of metals as therapeutic targets in
Alzheimer's disease. J. Am. Geriatr. Soc. 2003; 51:1143–1148. [PubMed: 12890080]
96. Gazaryan IG, Krasnikov BF, Ashby GA, Thorneley RNF, Kristal BS, Brown AM. Zinc is a potent
inhibitor of thiol oxidoreductase activity and stimulates reactive oxygen species production by
lipoamide dehydrogenase. J. Biol. Chem. 2002; 277:10064–10072. [PubMed: 11744691]
97. Corbett MD, Corbett BR. Effect of ring substituents on the transketolasecatalyzed conversion of
nitroso aromatics to hydroxamic acids. Biochem. Pharmacol. 1986; 35:3613–3621. [PubMed:
3768044]
98. Yoshioka T, Uematsu T. Biotransformation of nitroso aromatic compounds and 2-oxo acids to N-
hydroxy-N-arylacylamides by thiamine-dependent enzymes in rat liver. Drug Metab. Dispos.
1998; 26:705–710. [PubMed: 9660854]
99. Yoshioka T, Ohno H, Uematsu T. Pyruvate dehydrogenase complex-catalyzed formation of N-
arylacetohydroxamic acids from nitroso aromatic compounds in rat isolated cells and perfused
organs. J. Pharmacol. Exp. Ther. 1996; 279:1282–1289. [PubMed: 8968352]
100. Ferguson LR. Natural and human-made mutagens and carcinogens in the human diet. Toxicology.
2002; 181–182:79–82.
BUNIK et al. Page 29













101. Kangsadalampai K, Butryee C, Manoonphol K. Direct mutagenicity of the polycylic aromatic
hydrocarbon-containing fraction of smoked and charcoal-broiled foods treated with nitrite in acid
solution. Food Chem. Toxicol. 1997; 35:213–218. [PubMed: 9146734]
102. Yang D, Tannenbaum SR, Büuchi G, Lee GC. 4-Chloro-6-methoxyindole is the precursor of a
potent mutagen (4-chloro-6-methoxy-2-hydroxy-1-nitrosoindolin-3-one oxime) that forms during
nitrosation of the fava bean (Vicia faba). Carcinogenesis. 1984; 5:1219–1224. [PubMed:
6548421]
103. Ivankovic S, Seibel J, Komitowski D, Spiegelhalder B, Preussmann R, Siddiqi M. Caffeine-
derived N-nitroso compounds: V. Carcinogenicity of mononitrosocaffeidine and
dinitrosocaffeidine in bd-ix rats. Carcinogenesis. 1998; 19:933–937. [PubMed: 9635885]
104. Lin JK, Wu SS, Chen JT. Mutagenicities of nitrosated carboline derivatives. Proc. Natl. Sci.
Counc. Repub. China B. 1986; 10:280–286. [PubMed: 3550849]
105. Tricker AR, Pfundstein B, Kälble T, Preussmann R. Secondary amine precursors to nitrosamines
in human saliva, gastric juice, blood, urine and faeces. Carcinogenesis. 1992; 13:563–568.
[PubMed: 1576707]
106. Kumano T, Yoshioka T, Uematsu T. Comparative effect of chemical structure of chlorinated N-
hydroxy-N-acyl-aminobiphenyl ethers and their related compounds on rat liver cytosol-catalyzed
transacylation. Drug Metab. Dispos. 1986; 14:487–493. [PubMed: 2873998]
107. Gibson GE, Blass JP, Beal MF, Bunik V. The α-ketoglutarate-dehydrogenase complex: a
mediator between mitochondria and oxidative stress in neurodegeneration. Mol. Neurobiol. 2005;
31:43–63. [PubMed: 15953811]
108. Ko LW, Sheu KF-R, Thaler HT, Markesbery WR, Blass JP. Selective loss of KGDHC-enriched
neurons in Alzheimer temporal cortex: Does mitochondrial variation contribute to selective
vulnerability? J. Mol. Neurosci. 2001; 17:361–369. [PubMed: 11859932]
109. Hefti F, Weiner WJ. Nerve growth factor and Alzheimer's disease. Ann. Neurol. 1986; 20:275–
281. [PubMed: 3532929]
110. Butterworth, RF.; Leong, DK. Thiamine deficiency (Wernicke's) encephalopathy:
pathophysiologic mechanisms and development of positron emission tomography (PET) ligands.
In: Bisswanger, H.; Schellenberger, A., editors. Biochemistry and Physiology of Thiamin
Diphosphate Enzymes. Intemann, Prien; Germany: 1996. p. 409-417.
111. Venkatraman A, Landar A, Davis AJ, Chamlee L, Sanderson T, Kim H, Page G, Pompilius M,
Ballinger S, Darley-Usmar V, Bailey SM. Modification of the mitochondrial proteome in
response to the stress of ethanol-dependent hepatotoxicity. J. Biol. Chem. 2004; 279:22092–
22101. [PubMed: 15033988]
112. Kabysheva MS, Storozhevykh TP, Pinelis VG, Bunik VI. Synthetic regulators of the 2-
oxoglutarate oxidative decarboxylation alleviate the glutamate excitotoxicity in cerebellar
granule neurons. Biochem. Pharmacol. 2009; 77:1531–1540. [PubMed: 19426691]
113. Graf A, Kabysheva M, Klimuk E, Trofimova L, Dunaeva T, Zundorf G, Kahlert S, Reiser G,
Storozhevykh T, Pinelis V, et al. Role of 2-oxoglutarate dehydrogenase in brain pathologies
involving glutamate neurotoxicity. J. Mol. Catal. B61. 2009; 60:80–87.
114. Kahlert S, Zündorf G, Reiser G. Glutamate-mediated influx of extracellular Ca2+ is coupled with
reactive oxygen species generation in cultured hippocampal neurons but not in astrocytes. J.
Neurosci. Res. 2005; 79:262–271. [PubMed: 15578732]
115. Bunik VI, Denton TT, Xu H, Thompson CM, Cooper AJL, Gibson GE. Phosphonate analogues of
α-ketoglutarate inhibit the activity of the α-ketoglutarate dehydrogenase complex isolated from
brain and in cultured cells. Biochemistry. 2005; 44:10552–10561. [PubMed: 16060664]
116. Bunik V, Kaehne T, Degtyarev D, Shcherbakova T, Reiser G. Novel isoform of 2-oxogluratate
dehydrogenase is identified in brain, but not in heart. FEBS J. 2008; 275:4990–5006. [PubMed:
18783430]
117. Bunik VI, Degtyarev D. Structure-function relationships in the 2-oxo acid dehydrogenase family:
substrate-specific signatures and functional predictions for the 2-oxoglutarate dehydrogenase-like
proteins. Proteins. 2008; 71:874–890. [PubMed: 18004749]
118. McCartney RG, Rice JE, Sanderson S, Bunik V, Lindsay H, Lindsay JG. Subunit interactions in
the mammalian α-ketoglutarate dehydrogenase complex: evidence for direct association of the
BUNIK et al. Page 30













α-ketoglutarate dehydrogenase (E1) and dihydrolipoamide dehydrogenase (E3) components. J.
Biol. Chem. 1998; 273:24158–24164. [PubMed: 9727038]
119. MacDonald MJ, Husain RD, Hoffmann-Benning S, Baker TR. Immunochemical identification of
coenzyme Q0-dihydrolipoamide adducts in the E2 components of the α-ketoglutarate and
pyruvate dehydrogenase complexes partially explains the cellular toxicity of coenzyme Q0. J.
Biol. Chem. 2004; 279:27278–27285. [PubMed: 15075342]
120. Elam JS, Malek K, Rodriguez JA, Doucette PA, Taylor AB, Hayward LJ, Cabelli DE, Valentine
JS, Hart PJ. An alternative mechanism of bicarbonate-mediated peroxidation by copper–zinc
superoxide dismutase: rates enhanced via proposed enzyme-associated peroxycarbonate
intermediate. J. Biol. Chem. 2003; 278:21032–21039. [PubMed: 12649272]
121. Liochev SI, Fridovich I. Carbon dioxide mediates Mn(II)-catalyzed decomposition of hydrogen
peroxide and peroxidation reactions. Proc. Natl. Acad. Sci. USA. 2004; 101:12485–12490.
[PubMed: 15310847]
122. Andrekopoulos C, Zhang H, Joseph J, Kalivendi S, Kalyanaraman B. Bicarbonate enhances α-
synuclein oligomerization and nitration: intermediacy of carbonate radical anion and nitrogen
dioxide radical. Biochem. J. 2004; 378:435–447. [PubMed: 14640973]
123. Berlett BS, Chock PB, Yim MB, Stadtman ER. Manganese(II) catalyzes the bicarbonate-
dependent oxidation of amino acids by hydrogen peroxide and the amino acid–facilitated
dismutation of hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 1990; 87:389–393. [PubMed:
2296594]
124. Gomazkova VS. Effect of thiamine pyrophosphate and of the ions of divalent metals on the
activity and stability of the α-ketoglutarate decarboxylase from the breast muscle of the pigeon
[Russian]. Biokhimiia. 1973; 38:756–762. [PubMed: 4791856]
125. Markiewicz J, Strumilo S. The effect of Mn2+ on the catalytic function of heart muscle 2-
oxoglutarate dehydrogenase complex. Biochem. Arch. 1997; 13:127–129.
126. Bunik V, Westphal AH, de Kok A. Kinetic properties of the 2-oxoglutarate dehydrogenase
complex from Azotobacter vinelandii evidence for the formation of a precatalytic complex with
2-oxoglutarate. Eur. J. Biochem. 2000; 267:3583–3591. [PubMed: 10848975]
BUNIK et al. Page 31














Proposed mechanism for the phenylacetaldehyde synthase (PAAS)-catalyzed reaction
leading to biosynthesis of phenylacetaldehyde from L-phenylalanine. For details see the text.
[Modified from (57).]
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α-Ketoglutarate dehydrogenase complex (KGDHC)–catalyzed reaction. In the first step, KG
reacts with the ThDP cofactor and is decarboxylated to generate CO2 and active aldehyde
(carbanion) at the active site of E1k (step 1). In the second step, ThDP is regenerated in the
E1k-catalyzed reductive transacylation reaction with the lipoyl residue covalently bound to
E2k (step 2). This thio ester contains a high-energy bond as depicted by ~. In the next step,
at the active site of E2k, coenzyme A reacts with the succinyl dihydrolipoyl thio ester to
generate the high-energy compound succinyl CoA and a dihydrolipoyl residue (step 3).
Subsequently, a disulfide linkage in the dihydrolipoyl residue is regenerated concomitant
with the 2e− reduction of E3(S-S)·FAD (step 4), which in turn is reoxidized back with NAD+
(step 5). [From (115), with permission.]
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Formation of KGDHC-dependent radical species and the thioredoxin-catalyzed dismutation
of KGDHC-bound dihydrolipoyl radicals. For a detailed discussion, see the text. [Modified
from (82).]
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TABLE 1
Carbanion-Forming Enzymes (Excluding PLP-Containing Enzymes) That Catalyze Oxygenase/Oxidase Side
Reactions
Enzyme
a Oxygenase or Oxidase Reaction Catalyzed
Ribulose 1,5-bisphosphate carboxylase/
oxygenase (Rubisco) Oxygenase
Ribulose 1,5-bisphosphate + O2 → phosphoglycolate + D-3-
phosphoglycerate
Acetolactate synthase Oxygenase
Pyruvate + O2 → peracetate + CO2 nonenzymatic: pyruvate +
peracetic acid → 2 acetate + CO2
Pyruvate decarboxylase Oxygenase
Pyruvate + O2 → peracetate + CO2 non-enzymatic: pyruvate +
peracetic acid → 2 acetate + CO2
Rhamnulose 1-phosphate aldolase Oxidase
1,3-Dihydroxyacetone phosphate + O2 → hydroxypyruvaldehyde
phosphate + H2O2
Fructose 1,6-bisphosphate aldolase Oxidase
1,3-Dihydroxyacetone phosphate + O2 → hydroxypyruvaldehyde
phosphate (or 3-phosphoglycerate) + H2O2
α-Ketoglutarate dehydrogenase Oxidase α-Ketoglutarate → succinate + CO2 + 2e
− (with various electron
acceptors)
a
The enzymes in this list have been purified from various sources. For simplicity the source is not identified. The only case where species
differences appear to make a difference is fructose 1,6-bisphosphate aldolase. The enzyme isolated from Staphylococcus aureus catalyzes a side
reaction with O2, whereas the enzyme isolated from rabbit muscle does not. For original references, see the text.
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TABLE 2
Carbanion-Forming PLP Enzymes That Catalyze Oxidation Reactions
Enzyme
a Oxygenase or Oxidase Reaction Catalyzed
Escherichia coli glutamate
decarboxylase (GAD) Oxidase Glutamate + O2 → succinic semialdehyde + NH4
+ + CO2 + H2O2
E. coli glutamate decarboxylase (GAD) Uncertain α-Methyl-L-glutamate +  → levulinate + NH4+ + CO2
Pig kidney dopa decarboxylase (DDC) Uncertain Aromatic amine +  → aromatic aldehyde + NH4+
Pig kidney dopa decarboxylase (DDC) Uncertain α-Methyl L-dopa +  → dihydroxyphenylacetone + NH4+ + CO2
Lactobacillus ornithine decarboxylase
(ODC) Uncertain
α-Methyl L-ornithine +  → 2-methyl-Δ1-pyrroline + NH4+ + CO2 +
H2O
Lactobacillus ornithine decarboxylase
(ODC) Uncertain Putrescine +  → Δ
1-pyrrolone + NH4+ + H2O
Hafnia alvei ornithine decarboxylase
(ODC) Oxidase L-Ornithine + O2 → Δ
1-pyrroline + NH4+ + CO2 + H2O2
Petunia phenylacetaldehyde synthase
(PAAS) Oxidase L-Phenylalanine + O2 → phenylacetaldehyde + NH4
+ + CO2 + H2O2
Petunia phenylacetaldehyde synthase
(PAAS) Oxidase α-Methyl-L-phenylalanine + O2 → phenylacetone + NH4
+ + CO2 + H2O2
a
In each case except PAAS, the reactions shown are side reactions (paracatalytic) with O2. With PAAS the reaction shown is the dominant
reaction. For E. coli GAD, H. alvei ODC, and petunia PAAS, oxidative decarboxylation results in stoichiometric formation of H2O2. The enzymes
catalyzing these reactions are thus clearly oxidases. For pig heart DDC and Lactobacillus ODC, where no H2O2 has been directly detected in the
oxidation reaction, the situation is not yet clear. For original references, see the text.
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TABLE 3
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b + NDa + + +
a
For details, see the text.
b
Not determined.
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TABLE 5
Maximal Reaction Rate (Vmax) and Apparent Rate Constant for Irreversible Inactivation Associated with
Turnover (kin), Characteristic of the Paracatalytic Reaction of E1k Oxidizing KG with Hexacyanoferrate(III)
a
Enzyme Source E1k Preparation KG: Hexacyanoferrate(III) Oxidoreduction Vmax (μmol/min·mg) kin (min−1)
Pigeon breast muscle Isolated E1k 0.2 0.12
Complex-bound E1k 4.2 0.05
Pig heart Complex-bound E1k 3.0 0.04
Azotobacter vinelandii Complex-bound E1k 2.0 0.08
a
The data for the mammalian and pigeon E1k are from (88). The data for the Azotobacter E1k are from (126).
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